KR101991428B1 - Heterocyclic compound and organic electronic device using the same - Google Patents
Heterocyclic compound and organic electronic device using the same Download PDFInfo
- Publication number
- KR101991428B1 KR101991428B1 KR1020150161021A KR20150161021A KR101991428B1 KR 101991428 B1 KR101991428 B1 KR 101991428B1 KR 1020150161021 A KR1020150161021 A KR 1020150161021A KR 20150161021 A KR20150161021 A KR 20150161021A KR 101991428 B1 KR101991428 B1 KR 101991428B1
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- group
- layer
- organic
- light emitting
- Prior art date
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title abstract description 6
- 239000010410 layer Substances 0.000 claims description 151
- 150000001875 compounds Chemical class 0.000 claims description 104
- 239000012044 organic layer Substances 0.000 claims description 27
- 238000002347 injection Methods 0.000 claims description 24
- 239000007924 injection Substances 0.000 claims description 24
- 230000000903 blocking effect Effects 0.000 claims description 10
- 230000005525 hole transport Effects 0.000 claims description 10
- 150000002894 organic compounds Chemical class 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 description 71
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 63
- 238000006243 chemical reaction Methods 0.000 description 56
- -1 phosphoryl group Chemical group 0.000 description 50
- 230000015572 biosynthetic process Effects 0.000 description 38
- 238000003786 synthesis reaction Methods 0.000 description 38
- 239000000463 material Substances 0.000 description 35
- 239000000203 mixture Substances 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- 125000001424 substituent group Chemical group 0.000 description 24
- 125000003118 aryl group Chemical group 0.000 description 23
- 239000011368 organic material Substances 0.000 description 22
- 238000002360 preparation method Methods 0.000 description 21
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 20
- 239000011541 reaction mixture Substances 0.000 description 19
- 239000007787 solid Substances 0.000 description 19
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 17
- 238000010992 reflux Methods 0.000 description 16
- 229910052739 hydrogen Inorganic materials 0.000 description 15
- 239000001257 hydrogen Substances 0.000 description 15
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 14
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 14
- 125000004432 carbon atom Chemical group C* 0.000 description 13
- 239000000758 substrate Substances 0.000 description 13
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- 230000032258 transport Effects 0.000 description 12
- VQGHOUODWALEFC-UHFFFAOYSA-N 2-phenylpyridine Chemical compound C1=CC=CC=C1C1=CC=CC=N1 VQGHOUODWALEFC-UHFFFAOYSA-N 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 239000002019 doping agent Substances 0.000 description 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 9
- 125000000217 alkyl group Chemical group 0.000 description 9
- 125000005843 halogen group Chemical group 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 7
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 7
- 229910052782 aluminium Inorganic materials 0.000 description 7
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 7
- 125000006267 biphenyl group Chemical group 0.000 description 7
- 125000000623 heterocyclic group Chemical group 0.000 description 7
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 7
- 229910000027 potassium carbonate Inorganic materials 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 125000001624 naphthyl group Chemical group 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 230000002378 acidificating effect Effects 0.000 description 5
- 239000010406 cathode material Substances 0.000 description 5
- 239000004927 clay Substances 0.000 description 5
- 238000000151 deposition Methods 0.000 description 5
- 229910052805 deuterium Inorganic materials 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000004770 highest occupied molecular orbital Methods 0.000 description 5
- PQXKHYXIUOZZFA-UHFFFAOYSA-M lithium fluoride Chemical compound [Li+].[F-] PQXKHYXIUOZZFA-UHFFFAOYSA-M 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- OJRUSAPKCPIVBY-KQYNXXCUSA-N C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(CP(=O)(O)O)O)O)O)I)N Chemical compound C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(CP(=O)(O)O)O)O)O)I)N OJRUSAPKCPIVBY-KQYNXXCUSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 125000003342 alkenyl group Chemical group 0.000 description 4
- 125000004429 atom Chemical group 0.000 description 4
- 229940125758 compound 15 Drugs 0.000 description 4
- 125000000753 cycloalkyl group Chemical group 0.000 description 4
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- WLPUWLXVBWGYMZ-UHFFFAOYSA-N tricyclohexylphosphine Chemical compound C1CCCCC1P(C1CCCCC1)C1CCCCC1 WLPUWLXVBWGYMZ-UHFFFAOYSA-N 0.000 description 4
- GCTFTMWXZFLTRR-GFCCVEGCSA-N (2r)-2-amino-n-[3-(difluoromethoxy)-4-(1,3-oxazol-5-yl)phenyl]-4-methylpentanamide Chemical compound FC(F)OC1=CC(NC(=O)[C@H](N)CC(C)C)=CC=C1C1=CN=CO1 GCTFTMWXZFLTRR-GFCCVEGCSA-N 0.000 description 3
- UDQTXCHQKHIQMH-KYGLGHNPSA-N (3ar,5s,6s,7r,7ar)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-d][1,3]thiazole-6,7-diol Chemical compound S1C(NCC)=N[C@H]2[C@@H]1O[C@H](C(F)F)[C@@H](O)[C@@H]2O UDQTXCHQKHIQMH-KYGLGHNPSA-N 0.000 description 3
- HCCNBKFJYUWLEX-UHFFFAOYSA-N 7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)-3-(pyrazin-2-ylmethylamino)pyrido[3,4-b]pyrazin-2-one Chemical compound O=C1N(CCOCCC)C2=CC(C=3C=NC(OC)=CC=3)=NC=C2N=C1NCC1=CN=CC=N1 HCCNBKFJYUWLEX-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- JQUCWIWWWKZNCS-LESHARBVSA-N C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F Chemical compound C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F JQUCWIWWWKZNCS-LESHARBVSA-N 0.000 description 3
- RMFGOIXYLHOLFA-UHFFFAOYSA-N COC(=O)C1=C(C=CC=C1)C1=CC(=CC(=C1)Cl)Br Chemical group COC(=O)C1=C(C=CC=C1)C1=CC(=CC(=C1)Cl)Br RMFGOIXYLHOLFA-UHFFFAOYSA-N 0.000 description 3
- 229940126639 Compound 33 Drugs 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- PNUZDKCDAWUEGK-CYZMBNFOSA-N Sitafloxacin Chemical compound C([C@H]1N)N(C=2C(=C3C(C(C(C(O)=O)=CN3[C@H]3[C@H](C3)F)=O)=CC=2F)Cl)CC11CC1 PNUZDKCDAWUEGK-CYZMBNFOSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- 229910045601 alloy Inorganic materials 0.000 description 3
- 239000000956 alloy Substances 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 229940125936 compound 42 Drugs 0.000 description 3
- 229940126545 compound 53 Drugs 0.000 description 3
- 229940125900 compound 59 Drugs 0.000 description 3
- 229920001940 conductive polymer Polymers 0.000 description 3
- 125000004093 cyano group Chemical group *C#N 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 125000001072 heteroaryl group Chemical group 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 125000002950 monocyclic group Chemical group 0.000 description 3
- 125000004957 naphthylene group Chemical group 0.000 description 3
- IOMMMLWIABWRKL-WUTDNEBXSA-N nazartinib Chemical compound C1N(C(=O)/C=C/CN(C)C)CCCC[C@H]1N1C2=C(Cl)C=CC=C2N=C1NC(=O)C1=CC=NC(C)=C1 IOMMMLWIABWRKL-WUTDNEBXSA-N 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 3
- 125000003367 polycyclic group Chemical group 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 125000005730 thiophenylene group Chemical group 0.000 description 3
- DDGPPAMADXTGTN-UHFFFAOYSA-N 2-chloro-4,6-diphenyl-1,3,5-triazine Chemical compound N=1C(Cl)=NC(C=2C=CC=CC=2)=NC=1C1=CC=CC=C1 DDGPPAMADXTGTN-UHFFFAOYSA-N 0.000 description 2
- DMEVMYSQZPJFOK-UHFFFAOYSA-N 3,4,5,6,9,10-hexazatetracyclo[12.4.0.02,7.08,13]octadeca-1(18),2(7),3,5,8(13),9,11,14,16-nonaene Chemical group N1=NN=C2C3=CC=CC=C3C3=CC=NN=C3C2=N1 DMEVMYSQZPJFOK-UHFFFAOYSA-N 0.000 description 2
- QENGPZGAWFQWCZ-UHFFFAOYSA-N 3-Methylthiophene Chemical compound CC=1C=CSC=1 QENGPZGAWFQWCZ-UHFFFAOYSA-N 0.000 description 2
- BWGRDBSNKQABCB-UHFFFAOYSA-N 4,4-difluoro-N-[3-[3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-thiophen-2-ylpropyl]cyclohexane-1-carboxamide Chemical compound CC(C)C1=NN=C(C)N1C1CC2CCC(C1)N2CCC(NC(=O)C1CCC(F)(F)CC1)C1=CC=CS1 BWGRDBSNKQABCB-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CDEKDXGDFZUSCQ-UHFFFAOYSA-N BrC1=CC(=CC=2C3=CC=CC=C3C(C1=2)(C)C)Cl Chemical compound BrC1=CC(=CC=2C3=CC=CC=C3C(C1=2)(C)C)Cl CDEKDXGDFZUSCQ-UHFFFAOYSA-N 0.000 description 2
- OYNMHANIWGBQHI-UHFFFAOYSA-N BrC1=CC(=CC=2C3=CC=CC=C3NC1=2)Cl Chemical compound BrC1=CC(=CC=2C3=CC=CC=C3NC1=2)Cl OYNMHANIWGBQHI-UHFFFAOYSA-N 0.000 description 2
- CHIPCEHWVLEUJJ-UHFFFAOYSA-N BrC=1C=C(C=C(C=1)Cl)C1=C(C=CC=C1)C(C)(C)O Chemical compound BrC=1C=C(C=C(C=1)Cl)C1=C(C=CC=C1)C(C)(C)O CHIPCEHWVLEUJJ-UHFFFAOYSA-N 0.000 description 2
- GTKMDPKQBVDGOY-UHFFFAOYSA-N C1=C(C=C2C(=C1Br)OC1=C2C=CC=C1)Cl Chemical compound C1=C(C=C2C(=C1Br)OC1=C2C=CC=C1)Cl GTKMDPKQBVDGOY-UHFFFAOYSA-N 0.000 description 2
- HEUYTQAQCDJGEE-UHFFFAOYSA-N C1=CC=CC=2C3=CC=CC=C3N(C1=2)C1=CC=C(C=C1)C1=CC(=CC=2C3=CC=CC=C3NC1=2)B1OC(C(O1)(C)C)(C)C Chemical compound C1=CC=CC=2C3=CC=CC=C3N(C1=2)C1=CC=C(C=C1)C1=CC(=CC=2C3=CC=CC=C3NC1=2)B1OC(C(O1)(C)C)(C)C HEUYTQAQCDJGEE-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- MGZLWADZLKMKIX-UHFFFAOYSA-N ClC1=CC2=C(OC3=C2C=CC=C3)C(=C1)C=1C=C(C=CC=1)C1=NC(=NC(=N1)C1=CC=CC=C1)C1=CC=CC=C1 Chemical compound ClC1=CC2=C(OC3=C2C=CC=C3)C(=C1)C=1C=C(C=CC=1)C1=NC(=NC(=N1)C1=CC=CC=C1)C1=CC=CC=C1 MGZLWADZLKMKIX-UHFFFAOYSA-N 0.000 description 2
- MIMGIUMTXNIFDO-UHFFFAOYSA-N ClC=1C=C(C=2C(C3=CC=CC=C3C=2C=1)(C)C)C1=NC(=NC(=N1)C1=CC=CC=C1)C1=CC=CC=C1 Chemical compound ClC=1C=C(C=2C(C3=CC=CC=C3C=2C=1)(C)C)C1=NC(=NC(=N1)C1=CC=CC=C1)C1=CC=CC=C1 MIMGIUMTXNIFDO-UHFFFAOYSA-N 0.000 description 2
- CQHSAUNOIABKKO-UHFFFAOYSA-N ClC=1C=C(C=2NC3=CC=CC=C3C=2C=1)C1=CC(=CC=C1)C1=NC(=NC(=N1)C1=CC=CC=C1)C1=CC=CC=C1 Chemical compound ClC=1C=C(C=2NC3=CC=CC=C3C=2C=1)C1=CC(=CC=C1)C1=NC(=NC(=N1)C1=CC=CC=C1)C1=CC=CC=C1 CQHSAUNOIABKKO-UHFFFAOYSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 125000000304 alkynyl group Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 239000010405 anode material Substances 0.000 description 2
- 150000004982 aromatic amines Chemical class 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 2
- 125000002529 biphenylenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C12)* 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 2
- 229940125904 compound 1 Drugs 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 238000004768 lowest unoccupied molecular orbital Methods 0.000 description 2
- 229910044991 metal oxide Inorganic materials 0.000 description 2
- 150000004706 metal oxides Chemical class 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 239000007773 negative electrode material Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 125000001715 oxadiazolyl group Chemical group 0.000 description 2
- MXQOYLRVSVOCQT-UHFFFAOYSA-N palladium;tritert-butylphosphane Chemical compound [Pd].CC(C)(C)P(C(C)(C)C)C(C)(C)C.CC(C)(C)P(C(C)(C)C)C(C)(C)C MXQOYLRVSVOCQT-UHFFFAOYSA-N 0.000 description 2
- 238000005240 physical vapour deposition Methods 0.000 description 2
- 229920000553 poly(phenylenevinylene) Polymers 0.000 description 2
- 229920000767 polyaniline Polymers 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 125000005551 pyridylene group Chemical group 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 125000000335 thiazolyl group Chemical group 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 238000001771 vacuum deposition Methods 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- ASGMFNBUXDJWJJ-JLCFBVMHSA-N (1R,3R)-3-[[3-bromo-1-[4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]-N,1-dimethylcyclopentane-1-carboxamide Chemical compound BrC1=NN(C2=NC(=NC=C21)N[C@H]1C[C@@](CC1)(C(=O)NC)C)C1=CC=C(C=C1)C=1SC(=NN=1)C ASGMFNBUXDJWJJ-JLCFBVMHSA-N 0.000 description 1
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 description 1
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 1
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
- QCSLIRFWJPOENV-UHFFFAOYSA-N (2-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC=C1F QCSLIRFWJPOENV-UHFFFAOYSA-N 0.000 description 1
- ODAXNYMENLFYMY-UHFFFAOYSA-N (2-methoxycarbonylphenyl)boronic acid Chemical compound COC(=O)C1=CC=CC=C1B(O)O ODAXNYMENLFYMY-UHFFFAOYSA-N 0.000 description 1
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 1
- IUSARDYWEPUTPN-OZBXUNDUSA-N (2r)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(1,3-thiazol-2-yl)phenyl]butan-2-yl]-2-methoxypropanamide Chemical compound C([C@H](NC(=O)[C@@H](C)OC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C(C=1)=CC=CC=1C1=NC=CS1 IUSARDYWEPUTPN-OZBXUNDUSA-N 0.000 description 1
- YJLIKUSWRSEPSM-WGQQHEPDSA-N (2r,3r,4s,5r)-2-[6-amino-8-[(4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1CNC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O YJLIKUSWRSEPSM-WGQQHEPDSA-N 0.000 description 1
- VIJSPAIQWVPKQZ-BLECARSGSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoyl]amino]-4,4-dimethylpentanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O VIJSPAIQWVPKQZ-BLECARSGSA-N 0.000 description 1
- STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 description 1
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 1
- HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 description 1
- MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 description 1
- OMBVEVHRIQULKW-DNQXCXABSA-M (3r,5r)-7-[3-(4-fluorophenyl)-8-oxo-7-phenyl-1-propan-2-yl-5,6-dihydro-4h-pyrrolo[2,3-c]azepin-2-yl]-3,5-dihydroxyheptanoate Chemical compound O=C1C=2N(C(C)C)C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C(C=3C=CC(F)=CC=3)C=2CCCN1C1=CC=CC=C1 OMBVEVHRIQULKW-DNQXCXABSA-M 0.000 description 1
- AAGDJXZCBGGXTI-UHFFFAOYSA-N (4-bromo-2-chlorophenyl)hydrazine;hydrochloride Chemical compound Cl.NNC1=CC=C(Br)C=C1Cl AAGDJXZCBGGXTI-UHFFFAOYSA-N 0.000 description 1
- YQOLEILXOBUDMU-KRWDZBQOSA-N (4R)-5-[(6-bromo-3-methyl-2-pyrrolidin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid Chemical compound CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl YQOLEILXOBUDMU-KRWDZBQOSA-N 0.000 description 1
- JWJQEUDGBZMPAX-UHFFFAOYSA-N (9-phenylcarbazol-3-yl)boronic acid Chemical compound C12=CC=CC=C2C2=CC(B(O)O)=CC=C2N1C1=CC=CC=C1 JWJQEUDGBZMPAX-UHFFFAOYSA-N 0.000 description 1
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 description 1
- ZYZCALPXKGUGJI-DDVDASKDSA-M (e,3r,5s)-7-[3-(4-fluorophenyl)-2-phenyl-5-propan-2-ylimidazol-4-yl]-3,5-dihydroxyhept-6-enoate Chemical compound C=1C=C(F)C=CC=1N1C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)=C(C(C)C)N=C1C1=CC=CC=C1 ZYZCALPXKGUGJI-DDVDASKDSA-M 0.000 description 1
- CRXBTDWNHVBEIC-UHFFFAOYSA-N 1,2-dimethyl-9h-fluorene Chemical group C1=CC=C2CC3=C(C)C(C)=CC=C3C2=C1 CRXBTDWNHVBEIC-UHFFFAOYSA-N 0.000 description 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
- FNKCOUREFBNNHG-UHFFFAOYSA-N 1,3-dibromo-5-chlorobenzene Chemical compound ClC1=CC(Br)=CC(Br)=C1 FNKCOUREFBNNHG-UHFFFAOYSA-N 0.000 description 1
- KKHFRAFPESRGGD-UHFFFAOYSA-N 1,3-dimethyl-7-[3-(n-methylanilino)propyl]purine-2,6-dione Chemical compound C1=NC=2N(C)C(=O)N(C)C(=O)C=2N1CCCN(C)C1=CC=CC=C1 KKHFRAFPESRGGD-UHFFFAOYSA-N 0.000 description 1
- WTAPZWXVSZMMDG-UHFFFAOYSA-N 1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].C=1C=CC=CC=1C=CC(=O)C=CC1=CC=CC=C1 WTAPZWXVSZMMDG-UHFFFAOYSA-N 0.000 description 1
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 description 1
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 description 1
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 1
- QXOGPTXQGKQSJT-UHFFFAOYSA-N 1-amino-4-[4-(3,4-dimethylphenyl)sulfanylanilino]-9,10-dioxoanthracene-2-sulfonic acid Chemical compound Cc1ccc(Sc2ccc(Nc3cc(c(N)c4C(=O)c5ccccc5C(=O)c34)S(O)(=O)=O)cc2)cc1C QXOGPTXQGKQSJT-UHFFFAOYSA-N 0.000 description 1
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000006023 1-pentenyl group Chemical group 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- HBQUOLGAXBYZGR-UHFFFAOYSA-N 2,4,6-triphenyl-1,3,5-triazine Chemical compound C1=CC=CC=C1C1=NC(C=2C=CC=CC=2)=NC(C=2C=CC=CC=2)=N1 HBQUOLGAXBYZGR-UHFFFAOYSA-N 0.000 description 1
- OTJZMNIBLUCUJZ-UHFFFAOYSA-N 2,4-diphenyl-1,3,5-triazine Chemical compound C1=CC=CC=C1C1=NC=NC(C=2C=CC=CC=2)=N1 OTJZMNIBLUCUJZ-UHFFFAOYSA-N 0.000 description 1
- FQMZXMVHHKXGTM-UHFFFAOYSA-N 2-(1-adamantyl)-n-[2-[2-(2-hydroxyethylamino)ethylamino]quinolin-5-yl]acetamide Chemical compound C1C(C2)CC(C3)CC2CC13CC(=O)NC1=CC=CC2=NC(NCCNCCO)=CC=C21 FQMZXMVHHKXGTM-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- PYRKKGOKRMZEIT-UHFFFAOYSA-N 2-[6-(2-cyclopropylethoxy)-9-(2-hydroxy-2-methylpropyl)-1h-phenanthro[9,10-d]imidazol-2-yl]-5-fluorobenzene-1,3-dicarbonitrile Chemical compound C1=C2C3=CC(CC(C)(O)C)=CC=C3C=3NC(C=4C(=CC(F)=CC=4C#N)C#N)=NC=3C2=CC=C1OCCC1CC1 PYRKKGOKRMZEIT-UHFFFAOYSA-N 0.000 description 1
- FMKGJQHNYMWDFJ-CVEARBPZSA-N 2-[[4-(2,2-difluoropropoxy)pyrimidin-5-yl]methylamino]-4-[[(1R,4S)-4-hydroxy-3,3-dimethylcyclohexyl]amino]pyrimidine-5-carbonitrile Chemical compound FC(COC1=NC=NC=C1CNC1=NC=C(C(=N1)N[C@H]1CC([C@H](CC1)O)(C)C)C#N)(C)F FMKGJQHNYMWDFJ-CVEARBPZSA-N 0.000 description 1
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 1
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 description 1
- NPRYCHLHHVWLQZ-TURQNECASA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynylpurin-8-one Chemical compound NC1=NC=C2N(C(N(C2=N1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C NPRYCHLHHVWLQZ-TURQNECASA-N 0.000 description 1
- ZIYRDJLAJYTELF-UHFFFAOYSA-N 2-bromo-4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1Br ZIYRDJLAJYTELF-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- LFOIDLOIBZFWDO-UHFFFAOYSA-N 2-methoxy-6-[6-methoxy-4-[(3-phenylmethoxyphenyl)methoxy]-1-benzofuran-2-yl]imidazo[2,1-b][1,3,4]thiadiazole Chemical compound N1=C2SC(OC)=NN2C=C1C(OC1=CC(OC)=C2)=CC1=C2OCC(C=1)=CC=CC=1OCC1=CC=CC=C1 LFOIDLOIBZFWDO-UHFFFAOYSA-N 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- UCFSYHMCKWNKAH-UHFFFAOYSA-N 4,4,5,5-tetramethyl-1,3,2-dioxaborolane Chemical compound CC1(C)OBOC1(C)C UCFSYHMCKWNKAH-UHFFFAOYSA-N 0.000 description 1
- DDTHMESPCBONDT-UHFFFAOYSA-N 4-(4-oxocyclohexa-2,5-dien-1-ylidene)cyclohexa-2,5-dien-1-one Chemical compound C1=CC(=O)C=CC1=C1C=CC(=O)C=C1 DDTHMESPCBONDT-UHFFFAOYSA-N 0.000 description 1
- WYFCZWSWFGJODV-MIANJLSGSA-N 4-[[(1s)-2-[(e)-3-[3-chloro-2-fluoro-6-(tetrazol-1-yl)phenyl]prop-2-enoyl]-5-(4-methyl-2-oxopiperazin-1-yl)-3,4-dihydro-1h-isoquinoline-1-carbonyl]amino]benzoic acid Chemical compound O=C1CN(C)CCN1C1=CC=CC2=C1CCN(C(=O)\C=C\C=1C(=CC=C(Cl)C=1F)N1N=NN=C1)[C@@H]2C(=O)NC1=CC=C(C(O)=O)C=C1 WYFCZWSWFGJODV-MIANJLSGSA-N 0.000 description 1
- XFJBGINZIMNZBW-CRAIPNDOSA-N 5-chloro-2-[4-[(1r,2s)-2-[2-(5-methylsulfonylpyridin-2-yl)oxyethyl]cyclopropyl]piperidin-1-yl]pyrimidine Chemical compound N1=CC(S(=O)(=O)C)=CC=C1OCC[C@H]1[C@@H](C2CCN(CC2)C=2N=CC(Cl)=CN=2)C1 XFJBGINZIMNZBW-CRAIPNDOSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 125000005330 8 membered heterocyclic group Chemical group 0.000 description 1
- 239000005725 8-Hydroxyquinoline Substances 0.000 description 1
- VIJYEGDOKCKUOL-UHFFFAOYSA-N 9-phenylcarbazole Chemical compound C1=CC=CC=C1N1C2=CC=CC=C2C2=CC=CC=C21 VIJYEGDOKCKUOL-UHFFFAOYSA-N 0.000 description 1
- FRYRJNHMRVINIZ-UHFFFAOYSA-N B1CCOO1 Chemical compound B1CCOO1 FRYRJNHMRVINIZ-UHFFFAOYSA-N 0.000 description 1
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical group N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZWUDEGBXGKFNFV-UHFFFAOYSA-N C1=CC=CC=2C3=CC=CC=C3N(C1=2)C1=CC=C(C=C1)C1=CC(=CC=2C3=CC=CC=C3NC1=2)C1=NC(=NC(=N1)C1=CC=CC=C1)C1=CC=CC=C1 Chemical compound C1=CC=CC=2C3=CC=CC=C3N(C1=2)C1=CC=C(C=C1)C1=CC(=CC=2C3=CC=CC=C3NC1=2)C1=NC(=NC(=N1)C1=CC=CC=C1)C1=CC=CC=C1 ZWUDEGBXGKFNFV-UHFFFAOYSA-N 0.000 description 1
- TUVVZEPDPDKVPZ-UHFFFAOYSA-N C1=CC=CC=2C3=CC=CC=C3N(C1=2)C1=CC=C(C=C1)C1=CC(=CC=2C3=CC=CC=C3NC1=2)Cl Chemical compound C1=CC=CC=2C3=CC=CC=C3N(C1=2)C1=CC=C(C=C1)C1=CC(=CC=2C3=CC=CC=C3NC1=2)Cl TUVVZEPDPDKVPZ-UHFFFAOYSA-N 0.000 description 1
- OPKKCPPTKYPCNJ-UHFFFAOYSA-N C1=CC=CC=2C3=CC=CC=C3NC12.CC1(OBOC1(C)C)C Chemical compound C1=CC=CC=2C3=CC=CC=C3NC12.CC1(OBOC1(C)C)C OPKKCPPTKYPCNJ-UHFFFAOYSA-N 0.000 description 1
- XDWWEWKFHWVARG-UHFFFAOYSA-N CC(C)C1=CC=CC=C1C2=CC(=CC(=C2)Br)Cl Chemical compound CC(C)C1=CC=CC=C1C2=CC(=CC(=C2)Br)Cl XDWWEWKFHWVARG-UHFFFAOYSA-N 0.000 description 1
- KCBAMQOKOLXLOX-BSZYMOERSA-N CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCCCNCCCONC(=O)C4=C(C(=C(C=C4)F)F)NC5=C(C=C(C=C5)I)F)O Chemical compound CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCCCNCCCONC(=O)C4=C(C(=C(C=C4)F)F)NC5=C(C=C(C=C5)I)F)O KCBAMQOKOLXLOX-BSZYMOERSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- TTXYISNHLBNCPE-UHFFFAOYSA-N ClC1=CC2=C(OC3=C2C=CC=C3)C(=C1)B1OC(C(O1)(C)C)(C)C Chemical compound ClC1=CC2=C(OC3=C2C=CC=C3)C(=C1)B1OC(C(O1)(C)C)(C)C TTXYISNHLBNCPE-UHFFFAOYSA-N 0.000 description 1
- XGGSTZHXPCIDIX-UHFFFAOYSA-N ClC1=CC2=C(OC3=C2C=CC=C3)C(=C1)C1=NC(=NC(=N1)C1=CC=CC=C1)C1=CC=CC=C1 Chemical compound ClC1=CC2=C(OC3=C2C=CC=C3)C(=C1)C1=NC(=NC(=N1)C1=CC=CC=C1)C1=CC=CC=C1 XGGSTZHXPCIDIX-UHFFFAOYSA-N 0.000 description 1
- AGBNVPBTFWOHKH-UHFFFAOYSA-N ClC1=CC2=C(OC3=C2C=CC=C3)C(=C1)C=1C=CC=2N(C3=CC=CC=C3C=2C=1)C1=CC=CC=C1 Chemical compound ClC1=CC2=C(OC3=C2C=CC=C3)C(=C1)C=1C=CC=2N(C3=CC=CC=C3C=2C=1)C1=CC=CC=C1 AGBNVPBTFWOHKH-UHFFFAOYSA-N 0.000 description 1
- TWTSCUKHFFPAME-UHFFFAOYSA-N ClC=1C=C(C=2C(C3=CC=CC=C3C=2C=1)(C)C)B1OC(C(O1)(C)C)(C)C Chemical compound ClC=1C=C(C=2C(C3=CC=CC=C3C=2C=1)(C)C)B1OC(C(O1)(C)C)(C)C TWTSCUKHFFPAME-UHFFFAOYSA-N 0.000 description 1
- 229940126657 Compound 17 Drugs 0.000 description 1
- 229940127007 Compound 39 Drugs 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 229910052688 Gadolinium Inorganic materials 0.000 description 1
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- LVDRREOUMKACNJ-BKMJKUGQSA-N N-[(2R,3S)-2-(4-chlorophenyl)-1-(1,4-dimethyl-2-oxoquinolin-7-yl)-6-oxopiperidin-3-yl]-2-methylpropane-1-sulfonamide Chemical compound CC(C)CS(=O)(=O)N[C@H]1CCC(=O)N([C@@H]1c1ccc(Cl)cc1)c1ccc2c(C)cc(=O)n(C)c2c1 LVDRREOUMKACNJ-BKMJKUGQSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 1
- QOVYHDHLFPKQQG-NDEPHWFRSA-N N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O Chemical compound N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O QOVYHDHLFPKQQG-NDEPHWFRSA-N 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- YXLXNENXOJSQEI-UHFFFAOYSA-L Oxine-copper Chemical compound [Cu+2].C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1 YXLXNENXOJSQEI-UHFFFAOYSA-L 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- NRCMAYZCPIVABH-UHFFFAOYSA-N Quinacridone Chemical compound N1C2=CC=CC=C2C(=O)C2=C1C=C1C(=O)C3=CC=CC=C3NC1=C2 NRCMAYZCPIVABH-UHFFFAOYSA-N 0.000 description 1
- 101100042909 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SNO2 gene Proteins 0.000 description 1
- 229910052772 Samarium Inorganic materials 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- XOLBLPGZBRYERU-UHFFFAOYSA-N SnO2 Inorganic materials O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229910052769 Ytterbium Inorganic materials 0.000 description 1
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 description 1
- SPXSEZMVRJLHQG-XMMPIXPASA-N [(2R)-1-[[4-[(3-phenylmethoxyphenoxy)methyl]phenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound C(C1=CC=CC=C1)OC=1C=C(OCC2=CC=C(CN3[C@H](CCC3)CO)C=C2)C=CC=1 SPXSEZMVRJLHQG-XMMPIXPASA-N 0.000 description 1
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 1
- PSLUFJFHTBIXMW-WYEYVKMPSA-N [(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-6-(2-pyridin-2-ylethylcarbamoyloxy)-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] acetate Chemical compound O([C@@H]1[C@@H]([C@]2(O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@@H]21)C=C)C)OC(=O)C)C(=O)NCCC1=CC=CC=N1 PSLUFJFHTBIXMW-WYEYVKMPSA-N 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- ZEEBGORNQSEQBE-UHFFFAOYSA-N [2-(3-phenylphenoxy)-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound C1(=CC(=CC=C1)OC1=NC(=CC(=C1)CN)C(F)(F)F)C1=CC=CC=C1 ZEEBGORNQSEQBE-UHFFFAOYSA-N 0.000 description 1
- ABRVLXLNVJHDRQ-UHFFFAOYSA-N [2-pyridin-3-yl-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound FC(C1=CC(=CC(=N1)C=1C=NC=CC=1)CN)(F)F ABRVLXLNVJHDRQ-UHFFFAOYSA-N 0.000 description 1
- SMNRFWMNPDABKZ-WVALLCKVSA-N [[(2R,3S,4R,5S)-5-(2,6-dioxo-3H-pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4S,5R,6R)-4-fluoro-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)C2C=CC(=O)NC2=O)[C@H](O)[C@@H](F)[C@@H]1O SMNRFWMNPDABKZ-WVALLCKVSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001454 anthracenes Chemical class 0.000 description 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 125000001769 aryl amino group Chemical group 0.000 description 1
- 125000005110 aryl thio group Chemical group 0.000 description 1
- 125000000732 arylene group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- YCOXTKKNXUZSKD-UHFFFAOYSA-N as-o-xylenol Natural products CC1=CC=C(O)C=C1C YCOXTKKNXUZSKD-UHFFFAOYSA-N 0.000 description 1
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 150000001556 benzimidazoles Chemical class 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 229910052790 beryllium Inorganic materials 0.000 description 1
- ATBAMAFKBVZNFJ-UHFFFAOYSA-N beryllium atom Chemical compound [Be] ATBAMAFKBVZNFJ-UHFFFAOYSA-N 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 1
- UFVXQDWNSAGPHN-UHFFFAOYSA-K bis[(2-methylquinolin-8-yl)oxy]-(4-phenylphenoxy)alumane Chemical compound [Al+3].C1=CC=C([O-])C2=NC(C)=CC=C21.C1=CC=C([O-])C2=NC(C)=CC=C21.C1=CC([O-])=CC=C1C1=CC=CC=C1 UFVXQDWNSAGPHN-UHFFFAOYSA-K 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- XOYLJNJLGBYDTH-UHFFFAOYSA-M chlorogallium Chemical compound [Ga]Cl XOYLJNJLGBYDTH-UHFFFAOYSA-M 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 229940125797 compound 12 Drugs 0.000 description 1
- 229940126543 compound 14 Drugs 0.000 description 1
- 229940126142 compound 16 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940125810 compound 20 Drugs 0.000 description 1
- 229940126086 compound 21 Drugs 0.000 description 1
- 229940126208 compound 22 Drugs 0.000 description 1
- 229940125833 compound 23 Drugs 0.000 description 1
- 229940125961 compound 24 Drugs 0.000 description 1
- 229940125846 compound 25 Drugs 0.000 description 1
- 229940125851 compound 27 Drugs 0.000 description 1
- 229940127204 compound 29 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 229940125877 compound 31 Drugs 0.000 description 1
- 229940125878 compound 36 Drugs 0.000 description 1
- 229940125807 compound 37 Drugs 0.000 description 1
- 229940127573 compound 38 Drugs 0.000 description 1
- 229940126540 compound 41 Drugs 0.000 description 1
- 229940125844 compound 46 Drugs 0.000 description 1
- 229940127271 compound 49 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 229940127113 compound 57 Drugs 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 150000004826 dibenzofurans Chemical class 0.000 description 1
- 125000005509 dibenzothiophenyl group Chemical group 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 150000002219 fluoranthenes Chemical class 0.000 description 1
- YLQWCDOCJODRMT-UHFFFAOYSA-N fluoren-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3C2=C1 YLQWCDOCJODRMT-UHFFFAOYSA-N 0.000 description 1
- 150000002220 fluorenes Chemical group 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 150000002240 furans Chemical class 0.000 description 1
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 1
- 229910052733 gallium Inorganic materials 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005549 heteroarylene group Chemical group 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 1
- 229910003437 indium oxide Inorganic materials 0.000 description 1
- PJXISJQVUVHSOJ-UHFFFAOYSA-N indium(iii) oxide Chemical compound [O-2].[O-2].[O-2].[In+3].[In+3] PJXISJQVUVHSOJ-UHFFFAOYSA-N 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 238000007641 inkjet printing Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- SNHMUERNLJLMHN-UHFFFAOYSA-N iodobenzene Chemical compound IC1=CC=CC=C1 SNHMUERNLJLMHN-UHFFFAOYSA-N 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- VQSRKMNBWMHJKY-YTEVENLXSA-N n-[3-[(4ar,7as)-2-amino-6-(5-fluoropyrimidin-2-yl)-4,4a,5,7-tetrahydropyrrolo[3,4-d][1,3]thiazin-7a-yl]-4-fluorophenyl]-5-methoxypyrazine-2-carboxamide Chemical compound C1=NC(OC)=CN=C1C(=O)NC1=CC=C(F)C([C@@]23[C@@H](CN(C2)C=2N=CC(F)=CN=2)CSC(N)=N3)=C1 VQSRKMNBWMHJKY-YTEVENLXSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002790 naphthalenes Chemical class 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- PIDFDZJZLOTZTM-KHVQSSSXSA-N ombitasvir Chemical compound COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C([C@H]2N([C@@H](CC2)C=2C=CC(NC(=O)[C@H]3N(CCC3)C(=O)[C@@H](NC(=O)OC)C(C)C)=CC=2)C=2C=CC(=CC=2)C(C)(C)C)C=C1 PIDFDZJZLOTZTM-KHVQSSSXSA-N 0.000 description 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 1
- 150000004866 oxadiazoles Chemical class 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229960003540 oxyquinoline Drugs 0.000 description 1
- 150000002964 pentacenes Chemical class 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- CSHWQDPOILHKBI-UHFFFAOYSA-N perylene Chemical compound C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 description 1
- FVDOBFPYBSDRKH-UHFFFAOYSA-N perylene-3,4,9,10-tetracarboxylic acid Chemical compound C=12C3=CC=C(C(O)=O)C2=C(C(O)=O)C=CC=1C1=CC=C(C(O)=O)C2=C1C3=CC=C2C(=O)O FVDOBFPYBSDRKH-UHFFFAOYSA-N 0.000 description 1
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 1
- 150000002987 phenanthrenes Chemical class 0.000 description 1
- 150000005041 phenanthrolines Chemical class 0.000 description 1
- 125000004625 phenanthrolinyl group Chemical group N1=C(C=CC2=CC=C3C=CC=NC3=C12)* 0.000 description 1
- 125000005561 phenanthryl group Chemical group 0.000 description 1
- 125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
- 125000001644 phenoxazinyl group Chemical group C1(=CC=CC=2OC3=CC=CC=C3NC12)* 0.000 description 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
- 229920002098 polyfluorene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000128 polypyrrole Polymers 0.000 description 1
- 229920000123 polythiophene Polymers 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 150000003220 pyrenes Chemical class 0.000 description 1
- 125000001725 pyrenyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- YYMBJDOZVAITBP-UHFFFAOYSA-N rubrene Chemical compound C1=CC=CC=C1C(C1=C(C=2C=CC=CC=2)C2=CC=CC=C2C(C=2C=CC=CC=2)=C11)=C(C=CC=C2)C2=C1C1=CC=CC=C1 YYMBJDOZVAITBP-UHFFFAOYSA-N 0.000 description 1
- KZUNJOHGWZRPMI-UHFFFAOYSA-N samarium atom Chemical compound [Sm] KZUNJOHGWZRPMI-UHFFFAOYSA-N 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 150000003413 spiro compounds Chemical class 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229940042055 systemic antimycotics triazole derivative Drugs 0.000 description 1
- 238000010345 tape casting Methods 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- IBBLKSWSCDAPIF-UHFFFAOYSA-N thiopyran Chemical compound S1C=CC=C=C1 IBBLKSWSCDAPIF-UHFFFAOYSA-N 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- TVIVIEFSHFOWTE-UHFFFAOYSA-K tri(quinolin-8-yloxy)alumane Chemical compound [Al+3].C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1 TVIVIEFSHFOWTE-UHFFFAOYSA-K 0.000 description 1
- KWQNQSDKCINQQP-UHFFFAOYSA-K tri(quinolin-8-yloxy)gallane Chemical compound C1=CN=C2C(O[Ga](OC=3C4=NC=CC=C4C=CC=3)OC=3C4=NC=CC=C4C=CC=3)=CC=CC2=C1 KWQNQSDKCINQQP-UHFFFAOYSA-K 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- NAWDYIZEMPQZHO-UHFFFAOYSA-N ytterbium Chemical compound [Yb] NAWDYIZEMPQZHO-UHFFFAOYSA-N 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 1
- YVTHLONGBIQYBO-UHFFFAOYSA-N zinc indium(3+) oxygen(2-) Chemical compound [O--].[Zn++].[In+3] YVTHLONGBIQYBO-UHFFFAOYSA-N 0.000 description 1
- HTPBWAPZAJWXKY-UHFFFAOYSA-L zinc;quinolin-8-olate Chemical compound [Zn+2].C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1 HTPBWAPZAJWXKY-UHFFFAOYSA-L 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/76—Dibenzothiophenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- H01L51/0073—
-
- H01L51/50—
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1088—Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1092—Heterocyclic compounds characterised by ligands containing sulfur as the only heteroatom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Electroluminescent Light Sources (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
본 출원은 헤테로고리 화합물 및 이를 포함하는 유기 전자 소자에 관한 것이다. The present application relates to heterocyclic compounds and organic electronic devices containing them.
Description
본 출원은 헤테로고리 화합물 및 이를 포함하는 유기 전자 소자에 관한 것이다. The present application relates to heterocyclic compounds and organic electronic devices containing them.
유기 전자 소자의 대표적인 예로는 유기 발광 소자가 있다. 일반적으로 유기 발광 현상이란 유기 물질을 이용하여 전기에너지를 빛에너지로 전환시켜주는 현상을 말한다. 유기 발광 현상을 이용하는 유기 발광 소자는 통상 양극과 음극 및 이 사이에 유기물층을 포함하는 구조를 가진다. 여기서 유기물층은 유기 발광 소자의 효율과 안정성을 높이기 위하여 각기 다른 물질로 구성된 다층의 구조로 이루어진 경우가 많으며, 예컨대 정공주입층, 정공수송층, 발광층, 전자수송층, 전자주입층 등으로 이루어 질 수 있다. 이러한 유기 발광 소자의 구조에서 두 전극 사이에 전압을 걸어주게 되면 양극에서는 정공이, 음극에서는 전자가 유기물층에 주입되게 되고, 주입된 정공과 전자가 만났을 때 엑시톤(exciton)이 형성되며, 이 엑시톤이 다시 바닥상태로 떨어질 때 빛이 나게 된다. A representative example of the organic electronic device is an organic light emitting device. In general, organic light emission phenomenon refers to a phenomenon in which an organic material is used to convert electric energy into light energy. An organic light emitting device using an organic light emitting phenomenon generally has a structure including an anode, a cathode, and an organic material layer therebetween. Here, in order to increase the efficiency and stability of the organic light emitting device, the organic material layer may have a multi-layer structure composed of different materials and may include a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, and an electron injection layer. When a voltage is applied between the two electrodes in the structure of such an organic light emitting device, holes are injected in the anode, electrons are injected into the organic layer in the cathode, excitons are formed when injected holes and electrons meet, When it falls back to the ground state, the light comes out.
상기와 같은 유기 발광 소자를 위한 새로운 재료의 개발이 계속 요구되고 있다. Development of new materials for such organic light emitting devices has been continuously required.
본 출원은 헤테로고리 화합물 및 이를 포함하는 유기 전자 소자를 제공하는 것이다.The present application provides a heterocyclic compound and an organic electronic device including the heterocyclic compound.
본 출원은 하기 화학식 1로 표시되는 화합물을 제공한다.The present application provides a compound represented by the following general formula (1).
[화학식 1][Chemical Formula 1]
화학식 1에 있어서, In formula (1)
Y는 O, S, NR 또는 CRR'이고,Y is O, S, NR or CRR '
상기 L1 및 L2는 서로 동일하거나 상이하고, 각각 독립적으로 직접결합; 치환 또는 비치환된 아릴렌기; 또는 치환 또는 비치환된 헤테로아릴렌기이며,L 1 and L 2 are the same or different and are each independently a direct bond; A substituted or unsubstituted arylene group; Or a substituted or unsubstituted heteroarylene group,
상기 Ar1 및 Ar2 중 어느 하나는 하기 그룹 1에서 선택되고, 나머지 하나는 하기 그룹 2에서 선택되며,Wherein one of Ar 1 and Ar 2 is selected from the
R, R', R2 및 R4 내지 R8은 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 할로겐기; 히드록시기; 니트로기; 시아노기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알케닐기; 치환 또는 비치환된 알키닐기; 치환 또는 비치환된 시클로알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 아릴옥시기; 치환 또는 비치환된 아릴티옥시기; 치환 또는 비치환된 아민기; 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로아릴기이며,R, R ', R 2 and R 4 to R 8 are the same or different from each other, and each independently hydrogen; heavy hydrogen; A halogen group; A hydroxy group; A nitro group; Cyano; A substituted or unsubstituted alkyl group; A substituted or unsubstituted alkenyl group; A substituted or unsubstituted alkynyl group; A substituted or unsubstituted cycloalkyl group; A substituted or unsubstituted alkoxy group; A substituted or unsubstituted aryloxy group; A substituted or unsubstituted arylthio group; A substituted or unsubstituted amine group; A substituted or unsubstituted aryl group; Or a substituted or unsubstituted heteroaryl group,
[그룹 1][Group 1]
[그룹 2][Group 2]
상기 그룹 1 및 2에 있어서,In
X는 N 또는 CR"이고, 각각의 구조식은 적어도 하나의 X는 N이며,X is N or CR ", wherein at least one X is N,
R" 및 R9 내지 R45는 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 할로겐기; 히드록시기; 니트로기; 시아노기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 알케닐기; 치환 또는 비치환된 알키닐기; 치환 또는 비치환된 시클로알킬기; 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로아릴기이며,R "and R 9 to R 45 are the same or different and are each independently hydrogen, heavy hydrogen; halogen; hydroxy group; nitro group; cyano group; a substituted or unsubstituted alkyl group; a substituted or unsubstituted alkenyl group; a substituted or A substituted or unsubstituted alkynyl group, a substituted or unsubstituted cycloalkyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group,
Ar3 및 Ar4는 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 치환 또는 비치환된 알킬; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로아릴기; 또는 Ar3 및 Ar4는 서로 연결하여 고리를 형성하고, Ar 3 and Ar 4 are the same or different from each other, and each independently hydrogen; heavy hydrogen; Substituted or unsubstituted alkyl; A substituted or unsubstituted aryl group; A substituted or unsubstituted heteroaryl group; Or Ar 3 and Ar 4 are connected to each other to form a ring,
a, b, d, l,p, t 및 o 는 0 내지 5의 정수이고, a, b, d, l, p, t and o are integers of 0 to 5,
c, h, k, m, n, q 및 u 는 0 내지 4의 정수이고,c, h, k, m, n, q and u are integers of 0 to 4,
g, j 및 r은 0 내지 6의 정수이고, g, j and r are integers of 0 to 6,
f 및 w 는 0 내지 7의 정수이고,f and w are integers of 0 to 7,
e 및 v는 0 내지 8의 정수이고, e and v are integers of from 0 to 8,
s 는 0 내지 9의 정수이다.s is an integer of 0 to 9;
점선(-----)은 L1 또는 L2에 결합되는 부위를 의미한다.The dotted line (-----) means a site to be bonded to L 1 or L 2 .
또한, 본 출원은 제1 전극; 상기 제1 전극과 대향하여 구비된 제2 전극; 및 상기 제1 전극과 상기 제2 전극 사이에 구비된 1층 이상의 유기물층을 포함하는 유기 전자 소자로서, 상기 유기물층 중 1층 이상은 전술한 화합물을 포함하는 것인 유기 전자 소자를 제공한다.The present application also includes a first electrode; A second electrode facing the first electrode; And at least one organic material layer provided between the first electrode and the second electrode, wherein at least one of the organic material layers includes the above-described compound.
본 출원의 일 실시상태에 따른 화합물은 유기 발광 소자를 비롯한 유기 전기 소자에 사용되어, 유기 전기 소자의 구동전압을 낮추고, 발광층으로 사용할 경우 정공과 전자를 효과적으로 전달하여 광효율을 향상시키며, 분자량을 적절히 조절하여 열안정성을 향상시켜 소자의 수명 특성을 향상시킬 수 있다.The compound according to one embodiment of the present application is used in organic electroluminescent devices including organic electroluminescent devices to lower the driving voltage of the organic electroluminescent device and to effectively transfer holes and electrons when used as a light emitting layer to improve light efficiency, The thermal stability can be improved to improve the lifetime characteristics of the device.
도 1은 기판(1), 양극(2), 발광층(3), 음극(4)이 순차적으로 적층된 유기 발광 소자의 예를 도시한 것이다.
도 2는 기판 (1), 양극(2), 정공주입층(5), 정공수송층(6), 발광층(3), 전자수송층(7) 및 음극(4)이 순차적으로 적층된 유기 발광 소자의 예를 도시한 것이다.
도 3은 화합물 15의 H-NMR 스팩트럼을 측정한 그래프이다.1 shows an example of an organic light emitting device in which a
2 shows an organic light emitting device in which a
3 is a graph showing the 1 H-NMR spectrum of Compound 15.
이하, 본 명세서에 대하여 더욱 상세하게 설명한다.Hereinafter, the present invention will be described in more detail.
본 명세서는 상기 화학식 1로 표시되는 화합물를 제공한다.The present invention provides a compound represented by the above formula (1).
본 출원의 일 실시상태에 따르면, 상기 화학식 1로 표시되는 화합물은 상기 코어 구조를 가짐으로써, 전자흡입성기와 전자공유성기를 인접하여 치환시킬 수 있고, 분자내에 전하이동(charge transfer)에 의한 에너지의 전달이 용이하게된다 또한 상기와 같은 위치에 치환기가 위치할 경우 HOMO(Highest Occupied Molecular Orbital)와 LUMO(Lowest Unoccupied Molecular Orbital)가 분리되어 전자와 정공에 대한 안정성을 향상시킬 수 있다.According to one embodiment of the present application, the compound represented by Formula 1 has the core structure, whereby the electron-withdrawing group and the electron-covalent group can be substituted adjacent to each other, and the energy When the substituent is located at such a position, HOMO (Highest Occupied Molecular Orbital) and LUMO (Lowest Unoccupied Molecular Orbital) can be separated to improve stability against electrons and holes.
본 명세서에서 치환기의 예시들은 아래에서 설명하나, 이에 한정되는 것은 아니다. Examples of substituents herein are described below, but are not limited thereto.
상기 "치환"이라는 용어는 화합물의 탄소 원자에 결합된 수소 원자가 다른 치환기로 바뀌는 것을 의미하며, 치환되는 위치는 수소 원자가 치환되는 위치 즉, 치환기가 치환 가능한 위치라면 한정하지 않으며, 2 이상 치환되는 경우, 2 이상의 치환기는 서로 동일하거나 상이할 수 있다.The term "substituted" means that the hydrogen atom bonded to the carbon atom of the compound is replaced with another substituent, and the substituted position is not limited as long as the substituent is a substitutable position, , Two or more substituents may be the same as or different from each other.
본 명세서에서 "치환 또는 비치환된" 이라는 용어는 중수소; 할로겐기; 시아노기; 니트로기; 히드록시기; 알킬기; 시클로알킬기; 알케닐기; 아민기; 포스포릴기; 아릴기; 및 헤테로고리기로 이루어진 군에서 선택된 1 또는 2 이상의 치환기로 치환되었거나 상기 예시된 치환기 중 2 이상의 치환기가 연결된 치환기로 치환되거나, 또는 어떠한 치환기도 갖지 않는 것을 의미한다. 예컨대, "2 이상의 치환기가 연결된 치환기"는 바이페닐기일 수 있다. 즉, 바이페닐기는 아릴기일 수도 있고, 2개의 페닐기가 연결된 치환기로 해석될 수 있다. As used herein, the term " substituted or unsubstituted " A halogen group; Cyano; A nitro group; A hydroxy group; An alkyl group; A cycloalkyl group; An alkenyl group; An amine group; A phosphoryl group; An aryl group; And a heterocyclic group, or that at least two of the substituents exemplified in the above exemplified substituents are substituted with a connected substituent, or have no substituent. For example, "a substituent to which at least two substituents are connected" may be a biphenyl group. That is, the biphenyl group may be an aryl group, and may be interpreted as a substituent in which two phenyl groups are connected.
본 명세서에 있어서, 할로겐기의 예로는 불소, 염소, 브롬 또는 요오드가 있다. In the present specification, examples of the halogen group include fluorine, chlorine, bromine or iodine.
본 명세서에 있어서, 상기 알킬기는 직쇄 또는 분지쇄일 수 있고, 탄소수는 특별히 한정되지 않으나 1 내지 50인 것이 바람직하다. 구체적인 예로는 메틸, 에틸, 프로필, n-프로필, 이소프로필, 부틸, n-부틸, 이소부틸, tert-부틸, sec-부틸, 1-메틸-부틸, 1-에틸-부틸, 펜틸, n-펜틸, 이소펜틸, 네오펜틸, tert-펜틸, 헥실, n-헥실, 1-메틸펜틸, 2-메틸펜틸, 4-메틸-2-펜틸, 3,3-디메틸부틸, 2-에틸부틸, 헵틸, n-헵틸, 1-메틸헥실, 시클로펜틸메틸, 시클로헥실메틸, 옥틸, n-옥틸, tert-옥틸, 1-메틸헵틸, 2-에틸헥실, 2-프로필펜틸, n-노닐, 2,2-디메틸헵틸, 1-에틸-프로필, 1,1-디메틸-프로필, 이소헥실, 2-메틸펜틸, 4-메틸헥실, 5-메틸헥실 등이 있으나, 이들에 한정되지 않는다.In the present specification, the alkyl group may be linear or branched, and the number of carbon atoms is not particularly limited, but is preferably 1 to 50. Specific examples include methyl, ethyl, propyl, n-propyl, isopropyl, butyl, n-butyl, isobutyl, tert-butyl, sec- N-pentyl, 3-dimethylbutyl, 2-ethylbutyl, heptyl, n-hexyl, Cyclohexylmethyl, octyl, n-octyl, tert-octyl, 1-methylheptyl, 2-ethylhexyl, 2-propylpentyl, n-nonyl, 2,2-dimethyl Heptyl, 1-ethyl-propyl, 1,1-dimethyl-propyl, isohexyl, 2-methylpentyl, 4-methylhexyl, 5-methylhexyl and the like.
본 명세서에 있어서, 시클로알킬기는 특별히 한정되지 않으나, 탄소수 3 내지 60인 것이 바람직하며, 구체적으로 시클로프로필, 시클로부틸, 시클로펜틸, 3-메틸시클로펜틸, 2,3-디메틸시클로펜틸, 시클로헥실, 3-메틸시클로헥실, 4-메틸시클로헥실, 2,3-디메틸시클로헥실, 3,4,5-트리메틸시클로헥실, 4-tert-부틸시클로헥실, 시클로헵틸, 시클로옥틸 등이 있으나, 이에 한정되지 않는다. In the present specification, the cycloalkyl group is not particularly limited, but preferably has 3 to 60 carbon atoms. Specific examples thereof include cyclopropyl, cyclobutyl, cyclopentyl, 3-methylcyclopentyl, 2,3-dimethylcyclopentyl, But are not limited to, 3-methylcyclohexyl, 4-methylcyclohexyl, 2,3-dimethylcyclohexyl, 3,4,5-trimethylcyclohexyl, 4-tert- butylcyclohexyl, cycloheptyl, Do not.
본 명세서에 있어서, 상기 알콕시기는 직쇄, 분지쇄 또는 고리쇄일 수 있다. 알콕시기의 탄소수는 특별히 한정되지 않으나, 탄소수 1 내지 20인 것이 바람직하다. 구체적으로, 메톡시, 에톡시, n-프로폭시, 이소프로폭시, i-프로필옥시, n-부톡시, 이소부톡시, tert-부톡시, sec-부톡시, n-펜틸옥시, 네오펜틸옥시, 이소펜틸옥시, n-헥실옥시, 3,3-디메틸부틸옥시, 2-에틸부틸옥시, n-옥틸옥시, n-노닐옥시, n-데실옥시, 벤질옥시, p-메틸벤질옥시 등이 될 수 있으나, 이에 한정되는 것은 아니다.In the present specification, the alkoxy group may be linear, branched or cyclic. The number of carbon atoms of the alkoxy group is not particularly limited, but is preferably 1 to 20 carbon atoms. Specific examples include methoxy, ethoxy, n-propoxy, isopropoxy, i-propyloxy, n-butoxy, isobutoxy, tert-butoxy, sec-butoxy, n-pentyloxy, neopentyloxy, N-hexyloxy, n-hexyloxy, 3,3-dimethylbutyloxy, 2-ethylbutyloxy, n-octyloxy, n-nonyloxy, n-decyloxy, benzyloxy, But is not limited thereto.
본 명세서에 있어서, 상기 알케닐기는 직쇄 또는 분지쇄일 수 있고, 탄소수는 특별히 한정되지 않으나, 2 내지 40인 것이 바람직하다. 구체적인 예로는 비닐, 1-프로페닐, 이소프로페닐, 1-부테닐, 2-부테닐, 3-부테닐, 1-펜테닐, 2-펜테닐, 3-펜테닐, 3-메틸-1-부테닐, 1,3-부타디에닐, 알릴, 1-페닐비닐-1-일, 2-페닐비닐-1-일, 2,2-디페닐비닐-1-일, 2-페닐-2-(나프틸-1-일)비닐-1-일, 2,2-비스(디페닐-1-일)비닐-1-일, 스틸베닐기, 스티레닐기 등이 있으나 이들에 한정되지 않는다.In the present specification, the alkenyl group may be straight-chain or branched, and the number of carbon atoms is not particularly limited, but is preferably 2 to 40. Specific examples include vinyl, 1-propenyl, isopropenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-pentenyl, Butenyl, allyl, 1-phenylvinyl-1-yl, 2-phenylvinyl-1-yl, (Diphenyl-1-yl) vinyl-1-yl, stilbenyl, stilenyl, and the like.
본 명세서에서 상기 아릴기가 단환식 아릴기인 경우 탄소수는 특별히 한정되지 않으나, 탄소수 6 내지 25인 것이 바람직하다. 구체적으로 단환식 아릴기로는 페닐기, 바이페닐기, 터페닐기 등이 될 수 있으나, 이에 한정되는 것은 아니다. In the present specification, when the aryl group is a monocyclic aryl group, the number of carbon atoms is not particularly limited, but is preferably 6 to 25 carbon atoms. Specific examples of the monocyclic aryl group include a phenyl group, a biphenyl group, a terphenyl group, and the like, but are not limited thereto.
상기 아릴기가 다환식 아릴기인 경우 탄소수는 특별히 한정되지 않으나. 탄소수 10 내지 24인 것이 바람직하다. 구체적으로 다환식 아릴기로는 나프틸기, 안트라세닐기, 페난트릴기, 파이레닐기, 페릴레닐기, 크라이세닐기, 플루오레닐기 등이 될 수 있으나, 이에 한정되는 것은 아니다.When the aryl group is a polycyclic aryl group, the number of carbon atoms is not particularly limited. And preferably has 10 to 24 carbon atoms. Specific examples of the polycyclic aryl group include naphthyl, anthracenyl, phenanthryl, pyrenyl, perylenyl, klychenyl, fluorenyl, and the like.
본 명세서에 있어서, 상기 플루오레닐기는 치환될 수 있으며, 인접한 치환기들이 서로 결합하여 고리를 형성할 수 있다.In the present specification, the fluorenyl group may be substituted, and adjacent substituents may be bonded to each other to form a ring.
상기 플루오레닐기가 치환되는 경우, , , , , , 등이 될 수 있으나, 이에 한정되는 것은 아니다.When the fluorenyl group is substituted, , , , , , And the like, but the present invention is not limited thereto.
본 명세서에 있어서, 헤테로고리기는 탄소가 아닌 원자, 이종원자를 1 이상 포함하는 것으로서, 구체적으로 상기 이종 원자는 O, N, Se 및 S 등으로 이루어진 군에서 선택되는 원자를 1 이상 포함할 수 있다. 헤테로고리기의 탄소수는 특별히 한정되지 않으나, 탄소수 2 내지 60인 것이 바람직하다. 헤테로고리기의 예로는 티오페닐기, 퓨라닐기, 피롤기, 이미다졸릴기, 티아졸릴기, 옥사졸릴기, 옥사디아졸릴기, 트리아졸릴기, 피리딜기, 비피리딜기, 피리미딜기, 트리아지닐기, 아크리딜기, 하이드로아크리딜기(예컨대, ), 피리다지닐기, 피라지닐기, 퀴놀리닐기, 퀴나졸리닐기, 퀴녹살리닐기, 프탈라지닐기, 피리도피리미디닐기, 피리도피라지닐기, 피라지노피라지닐기, 이소퀴놀리닐기, 인돌기, 카바졸릴기, 벤즈옥사졸릴기, 벤즈이미다졸릴기, 벤조티아졸릴기, 벤조카바졸릴기, 디벤조카바졸릴기, 벤조티오페닐기, 디벤조티오페닐기, 벤조퓨라닐기, 디벤조퓨라닐기; 벤조실롤기; 디벤조실롤기; 페난트롤리닐기(phenanthrolinyl group), 티아졸릴기, 이소옥사졸릴기, 옥사디아졸릴기, 티아디아졸릴기, 벤조티아졸릴기, 페노티아지닐기, 페노옥사지닐기, 및 이들의 축합구조 등이 있으나, 이들에만 한정되는 것은 아니다. 이외에도 헤테로고리기의 예로서, 술포닐기를 포함하는 헤테로고리 구조, 예컨대, , 등이 있다.In the present specification, the heterocyclic group includes at least one non-carbon atom or hetero atom, and specifically, the hetero atom may include at least one atom selected from the group consisting of O, N, Se and S, and the like. The number of carbon atoms of the heterocyclic group is not particularly limited, but is preferably 2 to 60 carbon atoms. Examples of the heterocyclic group include thiophenyl group, furanyl group, pyrrolyl group, imidazolyl group, thiazolyl group, oxazolyl group, oxadiazolyl group, triazolyl group, pyridyl group, bipyridyl group, pyrimidyl group, Group, an acridyl group, a hydroacridyl group (e.g., ), A pyridazinyl group, a pyrazinyl group, a quinolinyl group, a quinazolinyl group, a quinoxalinyl group, a phthalazinyl group, a pyridopyrimidinyl group, a pyridopyranyl group, a pyrazinopyrazinyl group, an isoquinolinyl group , An indole group, a carbazolyl group, a benzoxazolyl group, a benzimidazolyl group, a benzothiazolyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, a benzothiophenyl group, a dibenzothiophenyl group, a benzofuranyl group, A furanyl group; Benzosyl group; Dibenzosilyl groups; A phenanthrolinyl group, a thiazolyl group, an isoxazolyl group, an oxadiazolyl group, a thiadiazolyl group, a benzothiazolyl group, a phenothiazinyl group, a phenoxazinyl group, and condensation structures thereof , But are not limited thereto. In addition, examples of the heterocyclic group include a heterocyclic structure including a sulfonyl group, , .
본 명세서에 있어서, 상기 축합구조는 해당 치환기에 방향족 탄소수소 고리가 축합된 구조일 수 있다. 예컨대, 벤즈이미다졸의 축합고리로서 ,, 등이 될 수 있으나, 이에 한정되는 것은 아니다.In the present specification, the condensed structure may be a structure in which an aromatic carbon-hydrogen ring is condensed with the substituent. For example, as a condensation ring of benzimidazole , , And the like, but the present invention is not limited thereto.
본 명세서에 있어서, "인접한" 기는 해당 치환기가 치환된 원자와 직접 연결된 원자에 치환된 치환기, 해당 치환기와 입체구조적으로 가장 가깝게 위치한 치환기, 또는 해당 치환기가 치환된 원자에 치환된 다른 치환기를 의미할 수 있다. 예컨대, 벤젠고리에서 오쏘(ortho)위치로 치환된 2개의 치환기 및 지방족 고리에서 동일 탄소에 치환된 2개의 치환기는 서로 "인접한" 기로 해석될 수 있다.As used herein, the term "adjacent" means that the substituent is a substituent substituted on an atom directly connected to the substituted atom, a substituent stereostructically closest to the substituent, or another substituent substituted on the substituted atom . For example, two substituents substituted at the ortho position in the benzene ring and two substituents substituted at the same carbon in the aliphatic ring may be interpreted as "adjacent" groups to each other.
본 명세서에 있어서, 인접한 기가 서로 결합하여 고리를 형성하는 것의 의미는 전술한 바와 같이 인접한 기가 서로 결합하여, 5원 내지 8원의 탄화수소 고리 또는 5원 내지 8원의 헤테로고리를 형성하는 것을 의미하며, 단환 또는 다환일 수 있으며, 지방족, 방향족 또는 이들의 축합된 형태일 수 있으며 이를 한정하지 않는다.In the present specification, the adjacent groups bonded to each other to form a ring means that adjacent groups are bonded to each other to form a 5-membered to 8-membered hydrocarbon ring or a 5-to 8-membered heterocyclic ring as described above , Monocyclic or polycyclic, and may be aliphatic, aromatic, or condensed forms thereof, but is not limited thereto.
본 출원의 일 실시상태에 따르면, 상기 Y는 O이다.According to one embodiment of the present application, Y is O.
본 출원의 일 실시상태에 따르면, 상기 Y는 S이다.According to one embodiment of the present application, Y is S.
본 출원의 일 실시상태에 따르면, 상기 Y는 NR이고, R은 화학식 1에서 정의한 바와 동일하다. According to one embodiment of the present application, Y is NR and R is the same as defined in formula (1).
본 출원의 일 실시상태에 따르면, 상기 Y는 NR이고, R은 치환 또는 비치환된 아릴기이다. According to one embodiment of the present application, Y is NR and R is a substituted or unsubstituted aryl group.
본 출원의 일 실시상태에 따르면, 상기 Y는 NR이고, R은 아릴기이다. According to one embodiment of the present application, Y is NR and R is an aryl group.
본 출원의 일 실시상태에 따르면, 상기 Y는 NR이고, R은 페닐기이다. According to one embodiment of the present application, Y is NR and R is a phenyl group.
본 출원의 일 실시상태에 따르면, 상기 Y는 CRR'이고, R 및 R'은 화학식 1에서 정의한 바와 동일하다.According to one embodiment of the present application, Y is CRR ', and R and R' are the same as defined in formula (1).
본 출원의 일 실시상태에 따르면, 상기 Y는 CRR'이고, R 및 R'은 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 할로겐기; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기이다. According to one embodiment of the present application, Y is CRR ', R and R' are the same or different and each independently hydrogen; heavy hydrogen; A halogen group; A substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group.
본 출원의 일 실시상태에 따르면, 상기 Y는 CRR'이고, R 및 R'은 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 또는 치환 또는 비치환된 알킬기이다. According to one embodiment of the present application, Y is CRR ', R and R' are the same or different and each independently hydrogen; heavy hydrogen; Or a substituted or unsubstituted alkyl group.
본 출원의 일 실시상태에 따르면, 상기 Y는 CRR'이고, R 및 R'은 메틸기이다.According to one embodiment of the present application, Y is CRR ', and R and R' are methyl groups.
본 출원의 일 실시상태에 따르면, 상기 L1 및 L2는 서로 동일하거나 상이하고, 각각 독립적으로 직접결합; 치환 또는 비치환된 페닐렌기; 치환 또는 비치환된 2가의 바이페닐릴렌기; 치환 또는 비치환된 나프틸렌기; 치환 또는 비치환된 티오페닐렌기; 치환 또는 비치환된 피리딜렌기; 치환 또는 비치환된 피리미딜렌기; 또는 치환 또는 비치환된 트리아지닐렌기이다.According to one embodiment of the present application, L < 1 > and L < 2 > are the same or different and are each independently a direct bond; A substituted or unsubstituted phenylene group; A substituted or unsubstituted divalent biphenyllylene group; A substituted or unsubstituted naphthylene group; A substituted or unsubstituted thiophenylene group; A substituted or unsubstituted pyridyl group; A substituted or unsubstituted pyrimidylene group; Or a substituted or unsubstituted triazylene group.
본 출원의 일 실시상태에 따르면, 상기 L1 은 직접결합이다.According to one embodiment of the present application, L < 1 > is a direct bond.
본 출원의 일 실시상태에 따르면, 상기 L1 은 페닐렌기이다.According to one embodiment of the present application, L < 1 > is a phenylene group.
본 출원의 일 실시상태에 따르면, 상기 L1 은 바이페닐릴렌기이다.According to one embodiment of the present application, L < 1 > is a biphenylene group.
본 출원의 일 실시상태에 따르면, 상기 L1 은 나프틸렌기이다.According to one embodiment of the present application, L < 1 > is a naphthylene group.
본 출원의 일 실시상태에 따르면, 상기 L1 은 티오페닐렌기이다.According to one embodiment of the present application, L < 1 > is a thiophenylene group.
본 출원의 일 실시상태에 따르면, 상기 L1 은 피디딜렌기이다.According to one embodiment of the present application, L < 1 > is a pyridylene group.
본 출원의 일 실시상태에 따르면, 상기 L1 은 피리미딜렌기이다.According to one embodiment of the present application, L < 1 > is a pyrimidylene group.
본 출원의 일 실시상태에 따르면, 상기 L1 은 트리아지닐렌기이다.According to one embodiment of the present application, L < 1 > is a triazylene group.
본 출원의 일 실시상태에 따르면, 상기 L2 은 직접결합이다.According to one embodiment of the present application, L < 2 > is a direct bond.
본 출원의 일 실시상태에 따르면, 상기 L2 은 페닐렌기이다.According to one embodiment of the present application, L < 2 > is a phenylene group.
본 출원의 일 실시상태에 따르면, 상기 L2 은 바이페닐릴렌기이다.According to one embodiment of the present application, L < 2 > is a biphenylene group.
본 출원의 일 실시상태에 따르면, 상기 L2 은 나프틸렌기이다.According to one embodiment of the present application, L < 2 > is a naphthylene group.
본 출원의 일 실시상태에 따르면, 상기 L2 은 티오페닐렌기이다.According to one embodiment of the present application, L < 2 > is a thiophenylene group.
본 출원의 일 실시상태에 따르면, 상기 L2 은 피디딜렌기이다.According to one embodiment of the present application, L < 2 > is a pyridylene group.
본 출원의 일 실시상태에 따르면, 상기 L2 은 피리미딜렌기이다.According to one embodiment of the present application, L < 2 > is a pyrimidylene group.
본 출원의 일 실시상태에 따르면, 상기 L2 은 트리아지닐렌기이다.According to one embodiment of the present application, L < 2 > is a triazylene group.
본 출원의 일 실시상태에 따르면, 상기 R9 내지 R39는 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 할로겐기; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기이다.According to one embodiment of the present application, R 9 to R 39 are the same or different from each other and each independently hydrogen; heavy hydrogen; A halogen group; A substituted or unsubstituted alkyl group; Or a substituted or unsubstituted aryl group.
본 출원의 일 실시상태에 따르면, 상기 R9 내지 R39는 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 할로겐기; 메틸기; 에틸기; 프로필기; i-프로필기; 부틸기; t-부틸기; 페닐기; 또는 나프틸기이다.According to one embodiment of the present application, R 9 to R 39 are the same or different from each other and each independently hydrogen; heavy hydrogen; A halogen group; Methyl group; An ethyl group; Propyl group; i-propyl; Butyl group; t-butyl group; A phenyl group; Or a naphthyl group.
본 출원의 일 실시상태에 따르면, 상기 R"은 수소; 중수소; 할로겐기; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기이다.According to one embodiment of the present application, R "is hydrogen, deuterium, a halogen group, a substituted or unsubstituted alkyl group, or a substituted or unsubstituted aryl group.
본 출원의 일 실시상태에 따르면, 상기 R"은 수소; 중수소; 할로겐기; 메틸기; 페닐기; 바이페닐기; 또는 나프틸기이다. According to one embodiment of the present application, R "is hydrogen, deuterium, halogen, methyl, phenyl, biphenyl or naphthyl.
본 출원의 일 실시상태에 따르면, 상기 Ar3 및 Ar4는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 아릴기이다.According to one embodiment of the present application, Ar 3 and Ar 4 are the same or different and are each independently a substituted or unsubstituted aryl group.
본 출원의 일 실시상태에 따르면, 상기 Ar3 및 Ar4는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 페닐기; 치환 또는 비치환된 바이페닐기; 치환 또는 비치환된 나프틸기; 또는 치환 또는 비치환된 플루오렌기이다.According to one embodiment of the present application, Ar 3 and Ar 4 are the same or different and are each independently a substituted or unsubstituted phenyl group; A substituted or unsubstituted biphenyl group; A substituted or unsubstituted naphthyl group; Or a substituted or unsubstituted fluorene group.
본 출원의 일 실시상태에 따르면, 상기 Ar3 및 Ar4는 서로 동일하거나 상이하고, 각각 독립적으로 페닐기; 바이페닐기; 나프틸기; 또는 디메틸 플루오렌기이다.According to one embodiment of the present application, Ar 3 and Ar 4 are the same or different from each other, and each independently represents a phenyl group; A biphenyl group; Naphthyl group; Or a dimethylfluorene group.
본 출원의 일 실시상태에 따르면, 상기 그룹 1은 하기 구조식들 중에서 선택되며, R9 내지 R15 및 a 내지 d는 화학식 1에서의 정의와 동일하다. According to one embodiment of the present application, the
본 출원의 일 실시상태에 따르면, 상기 R9 내지 R15는 각각 독립적으로, 수소, 중수소, 치환 또는 비치환된 아릴기이다.According to one embodiment of the present application, each of R9 to R15 is independently hydrogen, deuterium, or a substituted or unsubstituted aryl group.
본 출원의 일 실시상태에 따르면, 상기 R9 내지 R15는 각각 독립적으로, 수소, 중수소, 치환 또는 비치환된 페닐기, 치환 또는 비치환된 바이페닐기, 또는 치환 또는 비치환된 플루오레닐기이다.According to one embodiment of the present application, each of R9 to R15 is, independently, hydrogen, deuterium, a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, or a substituted or unsubstituted fluorenyl group.
본 출원의 일 실시상태에 따르면, 상기 R9 내지 R15는 각각 독립적으로, 수소, 중수소, 페닐기, 바이페닐기, 디메틸플루오레닐기이다.According to one embodiment of the present application, each of R9 to R15 independently represents hydrogen, deuterium, a phenyl group, a biphenyl group, or a dimethylfluorenyl group.
본 출원의 일 실시상태에 따르면, R2 및 R4 내지 R8은 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 할로겐기; C1 내지 C10의 알킬기; 또는 C6 내지 C20의 아릴기이다.According to one embodiment of the present application, R 2 and R 4 to R 8 are the same or different and each independently hydrogen; heavy hydrogen; A halogen group; A C 1 to C 10 alkyl group; Or a C 6 to C 20 aryl group.
본 출원의 일 실시상태에 따르면, R2 및 R4 내지 R8은 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 할로겐기; 메틸기; 에틸기; 프로필기; i-프로필기; 부틸기; t-부틸기; 페닐기; 또는 나프틸기이다.According to one embodiment of the present application, R 2 and R 4 to R 8 are the same or different and each independently hydrogen; heavy hydrogen; A halogen group; Methyl group; An ethyl group; Propyl group; i-propyl; Butyl group; t-butyl group; A phenyl group; Or a naphthyl group.
본 출원의 일 실시상태에 따르면, R2 및 R4 내지 R8은 수소이다.According to one embodiment of the present application, R 2 and R 4 to R 8 are hydrogen.
본 출원의 일 실시상태에 따르면, 상기 화학식 1로 표시되는 화합물은 하기 구조식들 중에서 선택된다. According to one embodiment of the present application, the compound represented by
본 출원의 일 실시상태에 따른 화합물은 후술하는 제조 방법으로 제조될 수 있다. The compound according to one embodiment of the present application can be produced by a production method described below.
예컨데, 상기 화학식 1의 화합물은 하기 반응식과 같이 코어구조가 제조될 수 있다.For example, the compound of
상기 반응식은 상기 화학식 1의 코어를 합성하는 방법의 예를 기재한 것일 뿐, 이에 한정되지 않으며, 필요에 따라 치환기의 종류 및 위치를 변경할 수 있다.The above reaction scheme is an example of a method of synthesizing the core of
치환기는 당기술분야에 알려져 있는 방법에 의하여 결합될 수 있으며, 치환기의 종류, 위치 또는 개수는 당기술분야에 알려져 있는 기술에 따라 변경될 수 있다.Substituent groups may be attached by methods known in the art, and the type, position or number of substituent groups may be varied according to techniques known in the art.
상기 반응식에서 L1, L2, Ar1 및 Ar2는 전술한 바와 동일하다.In the above reaction formula, L 1 , L 2 , Ar 1 and Ar 2 are the same as described above.
구체적인 제조방법은 후술하기로한다.A concrete manufacturing method will be described later.
또한, 본 명세서는 상기 전술한 화합물을 포함하는 유기 전자 소자를 제공한다. Further, the present invention provides an organic electronic device comprising the above-mentioned compounds.
본 출원의 일 실시상태에 있어서, 제1 전극; 상기 제1 전극과 대향하여 구비된 제2 전극; 및 상기 제1 전극과 상기 제2 전극 사이에 구비된 1층 이상의 유기물층을 포함하는 유기 전자 소자로서, 상기 유기물층 중 1 층 이상은 상기 화합물을 포함하는 것인 유기 전자 소자를 제공한다. In one embodiment of the present application, the first electrode; A second electrode facing the first electrode; And at least one organic compound layer provided between the first electrode and the second electrode, wherein at least one of the organic compound layers includes the compound.
본 명세서에서 어떤 부재가 다른 부재 "상에" 위치하고 있다고 할 때, 이는 어떤 부재가 다른 부재에 접해 있는 경우뿐 아니라 두 부재 사이에 또 다른 부재가 존재하는 경우도 포함한다.When a member is referred to herein as being "on " another member, it includes not only a member in contact with another member but also another member between the two members.
본 명세서에서 어떤 부분이 어떤 구성요소를 "포함" 한다고 할 때, 이는 특별히 반대되는 기재가 없는 한 다른 구성요소를 제외하는 것이 아니라 다른 구성 요소를 더 포함할 수 있는 것을 의미한다. Whenever a component is referred to as "comprising ", it is to be understood that the component may include other components as well, without departing from the scope of the present invention.
본 출원의 유기 전자 소자의 유기물층은 단층 구조로 이루어질 수도 있으나, 2층 이상의 유기물층이 적층된 다층 구조로 이루어질 수 있다. 예컨대, 본 발명의 유기 전자 소자의 대표 적인 예로서, 유기 발광 소자는 유기물층으로서 정공주입층, 정공수송층, 발광층, 전자수송층, 전자주입층 등을 포함하는 구조를 가질 수 있다. 그러나 유기 전자 소자의 구조는 이에 한정되지 않고 더 적은 수의 유기층을 포함할 수 있다.The organic material layer of the organic electronic device of the present application may have a single layer structure, but may have a multi-layer structure in which two or more organic material layers are stacked. For example, as a representative example of the organic electronic device of the present invention, the organic light emitting device may have a structure including a hole injecting layer, a hole transporting layer, a light emitting layer, an electron transporting layer, an electron injecting layer, etc. as an organic material layer. However, the structure of the organic electronic device is not limited thereto and may include a smaller number of organic layers.
본 출원의 일 실시상태에 따르면, 상기 유기 전자 소자는 유기발광소자, 유기인광소자, 유기태양전지, 유기감광체(OPC) 및 유기트랜지스터로 이루어진 군으로부터 선택될 수 있다.According to one embodiment of the present application, the organic electronic device may be selected from the group consisting of an organic light emitting device, an organic phosphorescent device, an organic solar cell, an organic photoconductor (OPC), and an organic transistor.
이하에서는 유기발광소자에 대하여 예시한다.Hereinafter, the organic light emitting device will be described.
본 출원의 일 실시상태에 있어서, 상기 유기물층은 발광층을 포함하고, 상기 발광층은 상기 화합물을 포함한다. In one embodiment of the present application, the organic layer includes a light emitting layer, and the light emitting layer includes the compound.
본 출원의 일 실시상태에 있어서, 상기 유기물층은 정공주입층 또는 정공수송층을 포함하고, 상기 정공주입층 또는 정공수송층은 상기 화합물을 포함한다. In one embodiment of the present application, the organic layer includes a hole injection layer or a hole transport layer, and the hole injection layer or the hole transport layer includes the compound.
또 하나의 실시상태에 있어서, 상기 유기물층은 발광층을 포함하고, 상기 발광층은 상기 화합물을 포함한다. In another embodiment, the organic layer includes a light emitting layer, and the light emitting layer includes the compound.
본 출원의 일 실시상태에 있어서, 상기 유기물층은 전자수송층 또는 전자주입층을 포함하고, 상기 전자수송층 또는 전자주입층은 상기 화합물을 포함한다. In one embodiment of the present application, the organic material layer includes an electron transporting layer or an electron injecting layer, and the electron transporting layer or the electron injecting layer includes the above compound.
본 출원의 일 실시상태에 있어서, 상기 유기물층은 전자저지층 또는 정공저지층을 포함하고, 상기 전자저지층 또는 정공저지층은 상기 화합물을 포함한다. In one embodiment of the present application, the organic layer includes an electron blocking layer or a hole blocking layer, and the electron blocking layer or the hole blocking layer includes the compound.
본 출원의 일 실시상태에 있어서, 상기 유기 발광 소자는 정공주입층, 정공수송층. 전자수송층, 전자주입층, 전자저지층 및 정공저지층으로 이루어진 군에서 선택되는 1층 또는 2층 이상을 더 포함한다.In one embodiment of the present application, the organic light emitting element is a hole injecting layer, a hole transporting layer. An electron transport layer, an electron injection layer, an electron blocking layer, and a hole blocking layer.
본 출원의 일 실시상태에 있어서, 상기 유기 발광 소자는 제1 전극; 상기 제1 전극과 대향하여 구비된 제2 전극; 및 상기 제1 전극과 상기 제2 전극 사이에 구비된 발광층; 상기 발광층과 상기 제1 전극 사이, 또는 상기 발광층과 상기 제2 전극 사이에 구비된 2층 이상의 유기물층을 포함하고, 상기 2층 이상의 유기물층 중 적어도 하나는 상기 화합물을 포함한다. 본 출원의 일 실시상태에 있어서, 상기 2층 이상의 유기물층은 전자수송층, 전자주입층, 전자 수송과 전자주입을 동시에 하는 층 및 정공저지층으로 이루어진 군에서 2 이상이 선택될 수 있다.In one embodiment of the present application, the organic light emitting device includes a first electrode; A second electrode facing the first electrode; And a light emitting layer provided between the first electrode and the second electrode; At least one of the two or more organic layers includes two or more organic layers disposed between the light emitting layer and the first electrode or between the light emitting layer and the second electrode. In one embodiment of the present application, the two or more organic layers may be selected from the group consisting of an electron transport layer, an electron injection layer, a layer that simultaneously transports electrons and electrons, and a hole blocking layer.
본 출원의 일 실시상태에 있어서, 상기 유기물층은 2층 이상의 전자수송층을 포함하고, 상기 2층 이상의 전자수송층 중 적어도 하나는 상기 화합물을 포함한다. 구체적으로 본 명세서의 일 실시상태에 있어서, 상기 화합물은 상기 2층 이상의 전자수송층 중 1층에 포함될 수도 있으며, 각각의 2층 이상의 전자수송층에 포함될 수 있다. In one embodiment of the present application, the organic material layer includes two or more electron transporting layers, and at least one of the two or more electron transporting layers includes the above compound. Specifically, in one embodiment of the present specification, the compound may be contained in one of the two or more electron transporting layers, and may be included in each of two or more electron transporting layers.
또한, 본 출원의 일 실시상태에 있어서, 상기 화합물이 상기 각각의 2층 이상의 전자수송층에 포함되는 경우, 상기 화합물을 제외한 다른 재료들은 서로 동일하거나 상이할 수 있다.In the embodiment of the present application, when the compound is contained in each of the two or more electron transporting layers, the materials other than the above compounds may be the same or different from each other.
본 출원의 일 실시상태에 있어서, 상기 유기물층은 상기 화합물을 포함하는 유기물층 이외에 아릴아미노기, 카바졸릴기 또는 벤조카바졸릴기를 포함하는 화합물을 포함하는 정공주입층 또는 정공수송층을 더 포함한다. In one embodiment of the present application, the organic layer further includes a hole injection layer or a hole transport layer containing a compound containing an arylamino group, a carbazolyl group or a benzocarbazolyl group in addition to the organic compound layer containing the compound.
본 명세서의 일 실시상태에 있어서, 상기 발광층은 화학식 1의 화합물을 포함하고, 발광 도펀트를 더 포함한다.In one embodiment of the present invention, the light emitting layer comprises a compound of the general formula (1), and further comprises a luminescent dopant.
또 하나의 실시상태에 있어서, 상기 발광도펀트는 인광도펀트를 포함한다.In another embodiment, the luminescent dopant comprises a phosphorescent dopant.
또 하나의 실시상태에 있어서, 상기 인광도펀트는 이리듐계 인광도펀트를 포함한다.In another embodiment, the phosphorescent dopant comprises an iridium phosphorescent dopant.
또 하나의 실시상태에 있어서, 상기 인광도펀트 물질은 Ir(ppy)3 를 포함한다.In another embodiment, the phosphorescent dopant material is Ir (ppy) 3 .
또 하나의 실시상태에 있어서, 유기 발광 소자는 기판 상에 양극, 1층 이상의 유기물층 및 음극이 순차적으로 적층된 구조(normal type)의 유기 발광 소자일 수 있다. In another embodiment, the organic light emitting device may be a normal type organic light emitting device in which an anode, at least one organic layer, and a cathode are sequentially stacked on a substrate.
또 하나의 실시상태에 있어서, 유기 발광 소자는 기판 상에 음극, 1층 이상의 유기물층 및 양극이 순차적으로 적층된 역방향 구조(inverted type)의 유기 발광 소자일 수 있다. In another embodiment, the organic light emitting device may be an inverted type organic light emitting device in which a cathode, at least one organic material layer, and an anode are sequentially stacked on a substrate.
예컨대, 본 출원의 일 실시상태에 따른 유기 발광 소자의 구조는 도 1 및 2에 예시되어 있다. For example, the structure of an organic light emitting device according to one embodiment of the present application is illustrated in Figs. 1 and 2. Fig.
도 1은 기판(1), 양극(2), 발광층(3), 음극(4)이 순차적으로 적층된 유기 전자 소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 화합물은 상기 발광층(3)에 포함될 수 있다. 1 shows a structure of an organic electronic device in which a
도 2는 기판 (1), 양극(2), 정공주입층(5), 정공수송층(6), 발광층(3), 전자수송층(7) 및 음극(4)이 순차적으로 적층된 유기 전자 소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서 상기 화합물은 상기 정공주입층(5), 정공 수송층(6), 발광층(3) 및 전자 수송층(7) 중 1층 이상에 포함될 수 있다. 2 shows an organic electronic device in which a
이와 같은 구조에 있어서, 상기 화합물은 상기 정공주입층, 정공수송층, 발광층 및 전자수송층 중 1층 이상에 포함될 수 있다. In such a structure, the compound may be contained in at least one of the hole injecting layer, the hole transporting layer, the light emitting layer, and the electron transporting layer.
본 출원의 유기 발광 소자는 유기물층 중 1층 이상이 본 출원의 화합물, 즉 상기 화합물을 포함하는 것을 제외하고는 당 기술분야에 알려져 있는 재료와 방법으로 제조될 수 있다.The organic light emitting device of the present application may be manufactured by materials and methods known in the art, except that one or more of the organic layers include the compound of the present application, i.e., the compound.
상기 유기 발광 소자가 복수개의 유기물층을 포함하는 경우, 상기 유기물층은 동일한 물질 또는 다른 물질로 형성될 수 있다. When the organic light emitting diode includes a plurality of organic layers, the organic layers may be formed of the same material or different materials.
본 출원의 유기 발광 소자는 유기물층 중 1층 이상이 상기 화합물, 즉 상기 화학식 1로 표시되는 화합물을 포함하는 것을 제외하고는 당 기술분야에 알려져 있는 재료와 방법으로 제조될 수 있다. The organic light emitting device of the present application can be produced by materials and methods known in the art, except that one or more of the organic layers include the above compound, that is, the compound represented by the above formula (1).
예컨대, 본 출원의 유기 발광 소자는 기판 상에 제1 전극, 유기물층 및 제2 전극을 순차적으로 적층시킴으로써 제조할 수 있다. 이 때 스퍼터링법(sputtering)이나 전자빔 증발법(e-beam evaporation)과 같은 PVD(physical Vapor Deposition)방법을 이용하여, 기판 상에 금속 또는 전도성을 가지는 금속 산화물 또는 이들의 합금을 증착시켜 양극을 형성하고, 그 위에 정공 주입층, 정공 수송층, 발광층 및 전자 수송층을 포함하는 유기물층을 형성한 후, 그 위에 음극으로 사용할 수 있는 물질을 증착시킴으로써 제조될 수 있다. 이와 같은 방법 외에도, 기판 상에 음극 물질부터 유기물층, 양극 물질을 차례로 증착시켜 유기 발광 소자를 만들 수 있다. For example, the organic light emitting device of the present application can be manufactured by sequentially laminating a first electrode, an organic material layer, and a second electrode on a substrate. At this time, by using a PVD (physical vapor deposition) method such as a sputtering method or an e-beam evaporation method, a metal or a metal oxide having conductivity or an alloy thereof is deposited on the substrate to form a positive electrode Forming an organic material layer including a hole injecting layer, a hole transporting layer, a light emitting layer and an electron transporting layer thereon, and depositing a material usable as a cathode thereon. In addition to such a method, an organic light emitting device can be formed by sequentially depositing a cathode material, an organic material layer, and a cathode material on a substrate.
또한, 상기 화학식 1의 화합물은 유기 발광 소자의 제조시 진공 증착법 뿐만 아니라 용액 도포법에 의하여 유기물층으로 형성될 수 있다. 여기서, 용액 도포법이라 함은 스핀 코팅, 딥코팅, 닥터 블레이딩, 잉크젯프린팅, 스크린 프린팅, 스프레이법, 롤 코팅 등을 의미하지만, 이들만으로 한정되는 것은 아니다. In addition, the compound of
본 출원의 일 실시상태에 있어서, 상기 제1 전극은 양극이고, 상기 제2 전극은 음극이다. In one embodiment of the present application, the first electrode is an anode and the second electrode is a cathode.
또 하나의 실시상태에 있어서, 상기 제1 전극은 음극이고, 상기 제2 전극은 양극이다. In another embodiment, the first electrode is a cathode and the second electrode is a cathode.
상기 양극 물질로는 통상 유기물층으로 정공 주입이 원활할 수 있도록 일함수가 큰 물질이 바람직하다. 본 발명에서 사용될 수 있는 양극 물질의 구체적인 예로는 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연 산화물, 인듐 산화물, 인듐주석 산화물(ITO), 인듐아연 산화물(IZO)과 같은 금속 산화물; ZnO:Al 또는 SNO2 : Sb와 같은 금속과 산화물의 조합; 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDOT), 폴리피롤 및 폴리아닐린과 같은 전도성 고분자 등이 있으나, 이들에만 한정되는 것은 아니다. As the anode material, a material having a large work function is preferably used so that hole injection can be smoothly conducted into the organic material layer. Specific examples of the cathode material that can be used in the present invention include metals such as vanadium, chromium, copper, zinc, and gold, or alloys thereof; Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); A combination of a metal and an oxide such as ZnO: Al or SNO2: Sb; Conductive polymers such as poly (3-methylthiophene), poly [3,4- (ethylene-1,2-dioxy) thiophene] (PEDOT), polypyrrole and polyaniline.
상기 음극 물질로는 통상 유기물층으로 전자 주입이 용이하도록 일함수가 작은 물질인 것이 바람직하다. 음극 물질의 구체적인 예로는 마그네슘, 칼슘, 나트륨, 칼륨, 티타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석 및 납과 같은 금속 또는 이들의 합금; LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등이 있으나, 이들에만 한정되는 것은 아니다. The negative electrode material is preferably a material having a small work function to facilitate electron injection into the organic material layer. Specific examples of the negative electrode material include metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin and lead or alloys thereof; Layer structure materials such as LiF / Al or LiO 2 / Al, but are not limited thereto.
상기 정공 주입 물질로는 전극으로부터 정공을 주입하는 층으로, 정공 주입 물질로는 정공을 수송하는 능력을 가져 양극에서의 정공 주입효과, 발광층 또는 발광재료에 대하여 우수한 정공 주입 효과를 갖고, 발광층에서 생성된 여기자의 전자주입층 또는 전자주입재료에의 이동을 방지하며, 또한, 박막 형성 능력이 우수한 화합물이 바람직하다. 정공 주입 물질의 HOMO(highest occupied molecular orbital)가 양극 물질의 일함수와 주변 유기물층의 HOMO 사이인 것이 바람직하다. 정공 주입 물질의 구체적인 예로는 금속 포피린(porphyrin), 올리고티오펜, 아릴아민 계열의 유기물, 헥사니트릴헥사아자트리페닐렌 계열의 유기물, 퀴나크리돈(quinacridone)계열의 유기물, 페릴렌(perylene) 계열의 유기물, 안트라퀴논 및 폴리아닐린과 폴리티오펜 계열의 전도성 고분자 등이 있으나, 이들에만 한정 되는 것은 아니다. The hole injecting material is a layer for injecting holes from the electrode. The hole injecting material has a hole injecting effect, a hole injecting effect in the anode, and an excellent hole injecting effect in the light emitting layer or the light emitting material. A compound which prevents the exciton from migrating to the electron injection layer or the electron injection material and is also excellent in the thin film forming ability is preferable. It is preferable that the highest occupied molecular orbital (HOMO) of the hole injecting material be between the work function of the anode material and the HOMO of the surrounding organic layer. Specific examples of the hole injecting material include metal porphyrin, oligothiophene, arylamine-based organic materials, hexanitrile hexaazatriphenylene-based organic materials, quinacridone-based organic materials, and perylene- , Anthraquinone, polyaniline and polythiophene-based conductive polymers, but the present invention is not limited thereto.
상기 정공수송층은 정공주입층으로부터 정공을 수취하여 발광층까지 정공을 수송하는 층으로, 정공 수송 물질로는 양극이나 정공 주입층으로부터 정공을 수송받아 발광층으로 옮겨줄 수 있는 물질로 정공에 대한 이동성이 큰 물질이 적합하다. 구체적인 예로는 아릴아민 계열의 유기물, 전도성 고분자, 및 공액 부분과 비공액 부분이 함께 있는 블록 공중합체 등이 있으나, 이들에만 한정되는 것은 아니다. The hole transport layer is a layer that transports holes from the hole injection layer to the light emitting layer. The hole transport material is a material capable of transporting holes from the anode or the hole injection layer to the light emitting layer. The material is suitable. Specific examples include arylamine-based organic materials, conductive polymers, and block copolymers having a conjugated portion and a non-conjugated portion together, but are not limited thereto.
상기 발광 물질로는 정공 수송층과 전자 수송층으로부터 정공과 전자를 각각 수송받아 결합시킴으로써 가시광선 영역의 빛을 낼 수 있는 물질로서, 형광이나 인광에 대한 양자 효율이 좋은 물질이 바람직하다. 구체적인 예로는 8-히드록시-퀴놀린 알루미늄 착물(Alq3); 카르바졸 계열 화합물; 이량체화 스티릴(dimerized styryl) 화합물; BAlq; 10-히드록시벤조 퀴놀린-금속 화합물; 벤족사졸, 벤즈티아졸 및 벤즈이미다졸 계열의 화합물; 폴리(p-페닐렌비닐렌)(PPV) 계열의 고분자; 스피로(spiro) 화합물; 폴리플루오렌, 루브렌 등이 있으나, 이들에만 한정되는 것은 아니다. The light emitting material is preferably a material capable of emitting light in the visible light region by transporting and receiving holes and electrons from the hole transporting layer and the electron transporting layer, respectively, and having good quantum efficiency for fluorescence or phosphorescence. Specific examples include 8-hydroxy-quinoline aluminum complex (Alq 3 ); Carbazole-based compounds; Dimerized styryl compounds; BAlq; 10-hydroxybenzoquinoline-metal compounds; Compounds of the benzoxazole, benzothiazole and benzimidazole series; Polymers of poly (p-phenylenevinylene) (PPV) series; Spiro compounds; Polyfluorene, rubrene, and the like, but are not limited thereto.
상기 발광층은 호스트 재료 및 도펀트 재료를 포함할 수 있다. 호스트 재료는 축합 방향족환 유도체 또는 헤테로환 함유 화합물 등이 있다. 구체적으로 축합 방향족환 유도체로는 안트라센 유도체, 피렌 유도체, 나프탈렌 유도체, 펜타센 유도체, 페난트렌 화합물, 플루오란텐 화합물 등이 있고, 헤테로환 함유 화합물로는 화합물, 디벤조퓨란 유도체, 래더형 퓨란 화합물, 피리미딘 유도체 등이 있으나, 이에 한정되지 않는다. The light emitting layer may include a host material and a dopant material. The host material is a condensed aromatic ring derivative or a heterocyclic compound. Specific examples of the condensed aromatic ring derivatives include anthracene derivatives, pyrene derivatives, naphthalene derivatives, pentacene derivatives, phenanthrene compounds, and fluoranthene compounds. Examples of heterocycle-containing compounds include compounds, dibenzofuran derivatives, ladder furan compounds , Pyrimidine derivatives, and the like, but are not limited thereto.
상기 전자 수송 물질로는 전자주입층으로부터 전자를 수취하여 발광층까지 전자를 수송하는 층으로 전자 수송 물질로는 음극으로부터 전자를 잘 주입 받아 발광층으로 옮겨줄 수 있는 물질로서, 전자에 대한 이동성이 큰 물질이 적합하다. 구체적인 예로는 8-히드록시퀴놀린의 Al착물; Alq3를 포함한 착물; 유기 라디칼 화합물; 히드록시플라본-금속 착물 등이 있으나, 이들에만 한정되는 것은 아니다. 전자 수송층은 종래기술에 따라 사용된 바와 같이 임의의 원하는 캐소드 물질과 함께 사용할 수 있다. 특히, 적절한 캐소드 물질의 예는 낮은 일함수를 가지고 알루미늄층 또는 실버층이 뒤따르는 통상적인 물질이다. 구체적으로 세슘, 바륨, 칼슘, 이테르븀 및 사마륨이고, 각 경우 알루미늄 층 또는 실버층이 뒤따른다.The electron transporting material is a layer that receives electrons from the electron injecting layer and transports electrons to the light emitting layer. The electron transporting material is a material capable of transferring electrons from the cathode well to the light emitting layer. Is suitable. Specific examples include an Al complex of 8-hydroxyquinoline; Complexes containing Alq 3 ; Organic radical compounds; Hydroxyflavone-metal complexes, and the like, but are not limited thereto. The electron transporting layer can be used with any desired cathode material as used according to the prior art. In particular, an example of a suitable cathode material is a conventional material having a low work function followed by an aluminum layer or a silver layer. Specifically cesium, barium, calcium, ytterbium and samarium, in each case followed by an aluminum layer or a silver layer.
상기 전자주입층은 전극으로부터 전자를 주입하는 층으로, 전자를 수송하는 능력을 갖고, 음극으로부터의 전자주입 효과, 발광층 또는 발광 재료에 대하여 우수한 전자주입 효과를 가지며, 발광층에서 생성된 여기자의 정공 주입층에의 이동을 방지하고, 또한, 박막형성능력이 우수한 화합물이 바람직하다. 구체적으로는 플루오레논, 안트라퀴노다이메탄, 다이페노퀴논, 티오피란 다이옥사이드, 옥사졸, 옥사다이아졸, 트리아졸, 이미다졸, 페릴렌테트라카복실산, 프레오레닐리덴 메탄, 안트론 등과 그들의 유도체, 금속 착체 화합물 및 함질소 5원환 유도체 등이 있으나, 이에 한정되지 않는다. The electron injection layer is a layer for injecting electrons from the electrode. The electron injection layer has the ability to transport electrons, has an electron injection effect from the cathode, and has an excellent electron injection effect with respect to the light emitting layer or the light emitting material. A compound which prevents migration to a layer and is excellent in a thin film forming ability is preferable. Specific examples thereof include fluorenone, anthraquinodimethane, diphenoquinone, thiopyran dioxide, oxazole, oxadiazole, triazole, imidazole, perylenetetracarboxylic acid, preorenylidene methane, A complex compound and a nitrogen-containing five-membered ring derivative, but are not limited thereto.
상기 금속 착체 화합물로서는 8-하이드록시퀴놀리나토 리튬, 비스(8-하이드록시퀴놀리나토)아연, 비스(8-하이드록시퀴놀리나토)구리, 비스(8-하이드록시퀴놀리나토)망간, 트리스(8-하이드록시퀴놀리나토)알루미늄, 트리스(2-메틸-8-하이드록시퀴놀리나토)알루미늄, 트리스(8-하이드록시퀴놀리나토)갈륨, 비스(10-하이드록시벤조[h]퀴놀리나토)베릴륨, 비스(10-하이드록시벤조[h]퀴놀리나토)아연, 비스(2-메틸-8-퀴놀리나토)클로로갈륨, 비스(2-메틸-8-퀴놀리나토)(o-크레졸라토)갈륨, 비스(2-메틸-8-퀴놀리나토)(1-나프톨라토)알루미늄, 비스(2-메틸-8-퀴놀리나토)(2-나프톨라토)갈륨 등이 있으나, 이에 한정되지 않는다.Examples of the metal complex compound include 8-hydroxyquinolinato lithium, bis (8-hydroxyquinolinato) zinc, bis (8-hydroxyquinolinato) copper, bis (8- Tris (8-hydroxyquinolinato) aluminum, tris (2-methyl-8-hydroxyquinolinato) aluminum, tris (8- hydroxyquinolinato) gallium, bis (10- Quinolinato) beryllium, bis (10-hydroxybenzo [h] quinolinato) zinc, bis (2-methyl-8- quinolinato) chlorogallium, bis (2-methyl-8-quinolinato) (2-naphtholato) gallium, and the like, But is not limited thereto.
상기 정공저지층은 정공의 음극 도달을 저지하는 층으로, 일반적으로 정공주입층과 동일한 조건으로 형성될 수 있다. 구체적으로 옥사디아졸 유도체나 트리아졸 유도체, 페난트롤린 유도체, BCP, 알루미늄 착물 (aluminum complex) 등이 있으나, 이에 한정되지 않는다. The hole blocking layer prevents holes from reaching the cathode, and may be formed under the same conditions as those of the hole injecting layer. Specific examples thereof include, but are not limited to, oxadiazole derivatives, triazole derivatives, phenanthroline derivatives, BCP, aluminum complexes and the like.
본 명세서에 따른 유기 발광 소자는 사용되는 재료에 따라 전면 발광형, 후면 발광형 또는 양면 발광형일 수 있다.The organic light emitting device according to the present invention may be of a top emission type, a back emission type, or a both-side emission type, depending on the material used.
본 출원의 일 실시상태에 있어서, 상기 화합물은 유기 발광 소자 외에도 유기 태양 전지 또는 유기 트랜지스터에 포함될 수 있다.In one embodiment of the present application, the compound may be included in an organic solar cell or an organic transistor in addition to the organic light emitting device.
본 출원에 따른 화합물은 유기인광소자, 유기태양전지, 유기감광체, 유기트랜지스터 등을 비롯한 유기 전자 소자에서도 유기 발광 소자에 적용되는 것과 유사한 원리로 작용할 수 있다.The compound according to the present application may act on a principle similar to that applied to organic light emitting devices in organic electronic devices including organic phosphorescent devices, organic solar cells, organic photoconductors, organic transistors and the like.
이하, 본 명세서를 구체적으로 설명하기 위해 실시예를 들어 상세하게 설명하기로 한다. 그러나, 본 명세서에 따른 실시예들은 여러 가지 다른 형태로 변형될 수 있으며, 본 출원의 범위가 아래에서 상술하는 실시예들에 한정되는 것으로 해석되지 않는다. 본 출원의 실시예들은 당업계에서 평균적인 지식을 가진 자에게 본 명세서를 보다 완전하게 설명하기 위해 제공되는 것이다.Hereinafter, the present invention will be described in detail by way of examples with reference to the drawings. However, the embodiments according to the present disclosure can be modified in various other forms, and the scope of the present application is not construed as being limited to the embodiments described below. The embodiments of the present application are provided to enable those skilled in the art to more fully understand the present invention.
<< 제조예Manufacturing example 1> 중간체 1의 합성 1> Synthesis of intermediate 1
(반응예 1-1) 1-1 의 합성(Reaction Example 1-1) Synthesis of 1-1
2-브로모-4-클로로페놀 50g(0.24mol)과 (2-플루오로페닐)보론산 37g(0.26mol)을 THF(테트라하이드로퓨란(Tetrahydrofuran)) 600mL에 녹이고, 100g(0.73mol)의 포타슘카보네이트를 녹인 수용액 200mL을 반응물에 첨가하여 가온하였다. 환류 상태에서 테트라키스(트리페닐포스핀)팔라듐(0) 2.8g (2.4mmol)을 투입하였다. 혼합물을 12시간 동안 환류 교반 시켰다. 반응 종결 후 실온으로 냉각하여 물 층을 버리고, 유기용매를 감압 농축하고 이를 다시 클로로포름을 첨가하여 녹인 후, 물로 두 번 세척하여 유기층을 분리하여 무수황산마그네슘으로 처리하고 여과 후 농축하여 오일상태의 화합물 1-1을 53 g (~100%) 얻었다. (0.24 mol) of 2-bromo-4-chlorophenol and 37 g (0.26 mol) of (2-fluorophenyl) boronic acid were dissolved in 600 mL of THF (tetrahydrofuran), 100 g (0.73 mol) Carbonate (200 mL) was added to the reaction solution, followed by heating. 2.8 g (2.4 mmol) of tetrakis (triphenylphosphine) palladium (0) was added thereto under reflux. The mixture was refluxed for 12 hours. After completion of the reaction, the reaction mixture was cooled to room temperature and the water layer was discarded. The organic solvent was concentrated under reduced pressure. The residue was dissolved in chloroform and washed twice with water. The organic layer was separated and treated with anhydrous magnesium sulfate, 53 g (-100%) of 1-1 was obtained.
(반응예 1-2) 1-2 의 합성 (Reaction Example 1-2) Synthesis of 1-2
오일 상태의 화합물 1-1 53g(0.24mol)을 N,N-다이메틸포름아마이드 400mL에 녹인 후 0℃로 냉각하여 N-브로모숙신이미드 38g(0.24mol)을 천천히 투입하여 교반시켰다. 같은 온도에서 2시간 동안 교반 한 후, 반응물을 물 2L에 희석한 후 에틸아세테이트로 추출하였다. 추출한 유기용매는 물로 2번 더 세척한 후 무수황산마그네슘으로 슬러리 후 여과하여 감압하에 농축하여 갈색의 오일(oil) 형태의 1-2 화합물을 72g(~100%) 얻었다. 53 g (0.24 mol) of compound 1-1 in oil were dissolved in 400 mL of N, N-dimethylformamide, and the mixture was cooled to 0 캜. 38 g (0.24 mol) of N-bromosuccinimide was slowly added thereto and stirred. After stirring at the same temperature for 2 hours, the reaction was diluted with 2 L of water and extracted with ethyl acetate. The extracted organic solvent was washed twice with water and then slurried with anhydrous magnesium sulfate, followed by filtration and concentration under reduced pressure to obtain 72 g (~ 100%) of 1-2 compounds in the form of an oil in the form of an oil.
(반응예 1-3) 중간체 1의 합성(Reaction Example 1-3) Synthesis of
오일 상태의 화합물 1-2 72g을 N-메틸-2-피롤리돈 200mL에 희석한 후 포타슘카보네이트 66g (0.48mol)을 첨가한 후 150℃까지 가온하여 4시간 정도 교반 시켰다. 반응이 완결된 후 실온으로 냉각하고, 석출된 고체를 여과하여 에탄올과 물로 씻어주었다. 여과된 고체를 클로로포름에 녹인 후 물로 2회 세척한 후 산성백토와 무수황산마그네슘으로 처리하여 여과 후 농축하였다. 농축한 화합물에 에탄올과 헥산을 첨가하여 실온에서 슬러리 정제 하였다. 이를 여과하여 흰색의 중간체 화합물 1을 40%의 수율로 27g 얻었다.72 g of the compound 1-2 in an oil state was diluted in 200 mL of N-methyl-2-pyrrolidone, and 66 g (0.48 mol) of potassium carbonate was added. The mixture was heated to 150 캜 and stirred for about 4 hours. After the reaction was completed, the reaction mixture was cooled to room temperature, and the precipitated solid was filtered and washed with ethanol and water. The filtered solid was dissolved in chloroform, washed twice with water, treated with acidic clay and anhydrous magnesium sulfate, filtered and concentrated. Ethanol and hexane were added to the concentrated compound and the slurry was purified at room temperature. This was filtered to obtain 27 g of a white
<< 제조예Manufacturing example 2> 중간체 2의 합성 2> Synthesis of intermediate 2
(반응예 2-1) 2-1의 합성(Reaction Example 2-1) Synthesis of 2-1
질소 기류 하에서 사이클로헥사논(50 g, 0.5mol)과 (4-브로모-2-클로로페닐)하이드라진 하이드로클로라이드(160g, 0.5mol)을 에타올 500mL에 희석한 후 가온하여 아세트산 1.5mL(0.025mol)을 첨가하였다. 12시간 동안 환류 상태로 교반하여 반응이 완결되면 실온으로 냉각하였다. 반응물을 감압농축하고 농축된 화합물은 에틸아세테이트에 녹인 후 다시 물로 2회 세척하였다. 유기층을 분리하여 무수황산마그네슘으로 처리하여 여과 후 농축하여 목적화합물 2-1 93 g(83%)을 얻었다. (50 g, 0.5 mol) and (4-bromo-2-chlorophenyl) hydrazine hydrochloride (160 g, 0.5 mol) were diluted with 500 mL of ethanol in a nitrogen stream and 1.5 mL (0.025 mol ). The mixture was stirred at reflux for 12 hours and cooled to room temperature when the reaction was complete. The reaction was concentrated under reduced pressure and the concentrated compound was dissolved in ethyl acetate and washed again twice with water. The organic layer was separated, treated with anhydrous magnesium sulfate, filtered and concentrated to obtain 93 g (83%) of the desired compound 2-1.
(반응예 2-2) 중간체 2의 합성(Reaction Example 2-2) Synthesis of
화합물 2-1 100g(0.35 mol) 을 테트라하이드로퓨란 700mL에 희석하고 4,5-디클로로-3,6-디옥시시클로헥사-1,4-디엔-1,2-디카보니트릴(118 g, 0.525mol)을 넣고 실온에서 교반하였다. 2시간 후 반응이 완결되면 감압 농축하여 용매를 제거하고, 농축된 화합물은 다시 클로로포름에 녹여서 실리카겔 여과하였다. 여과한 용액은 다시 농축하여 헥산과 클로로포름 10:1의 조건으로 컬럼크로마토그래피로 정제하여 목적화합물 2를 흰색의 고체로 68 g(70%) 얻었다. 100 g (0.35 mol) of Compound 2-1 was diluted in 700 mL of tetrahydrofuran, and 4,5-dichloro-3,6-dioxycyclohexa-1,4-diene-1,2-dicarbonitrile (118 g, 0.525 mol) and stirred at room temperature. After completion of the reaction, the reaction mixture was concentrated under reduced pressure to remove the solvent. The concentrated compound was dissolved again in chloroform and filtered through silica gel. The filtrate was concentrated again and purified by column chromatography under the conditions of hexane and chloroform 10: 1 to obtain 68 g (70%) of the
<<
제조예Manufacturing example
3> 화합물 3의 합성 3> Synthesis of
(반응예 3-1) 2-(3-(2-클로로디벤조[b,d]퓨란-4-일)페닐)-4,6-디페닐-1,3,5-트리아진의 합성(Reaction Example 3-1) Synthesis of 2- (3- (2-chlorodibenzo [b, d] furan-4-yl) phenyl) -4,6-diphenyl-1,3,5-triazine
4-브로모-2-클로로디벤조[b,d]퓨란 10g(0.035mol)과 2,4-디페닐-6-(3-(4,4,5,5-테드라메틸-1,3,2-디옥사보롤란-2-일)페닐)-1,3,5-트리아진 16.4 g(0.037mol)을 THF(테트라하이드로퓨란(Tetrahydrofuran)) 100mL에 녹이고, 14.5g(0.10 mol)의 포타슘카보네이트를 녹인 수용액 20mL를 반응물에 첨가하여 가온하였다. 환류 상태에서 테트라키스(트리페닐포스핀)팔라듐(0) 400 mg (0.35 mmol)을 투입하였다. 혼합물을 12시간 동안 환류 교반 시켰다. 반응 종결 후 실온으로 냉각하여 석출된 고체를 여과하고 물과 에틸아세테이트로 씻어 준었다. 여과된 고체를 에틸아세테이트에 희석한 후 가온하여 1시간 정도 슬러리 시키고, 실온으로 냉각하여 여과하였다. 흰색의 고체 27g(78%)을 얻었다. (0.035 mol) of 4-bromo-2-chlorodibenzo [b, d] furan and 2,4-diphenyl-6- (3- (4,4,5,5- Dioxaborolan-2-yl) phenyl) -1,3,5-triazine (16.4 g, 0.037 mol) was dissolved in 100 mL of THF (tetrahydrofuran) 20 mL of an aqueous solution containing potassium carbonate was added to the reaction mixture and the mixture was heated. 400 mg (0.35 mmol) of tetrakis (triphenylphosphine) palladium (0) was added thereto under reflux. The mixture was refluxed for 12 hours. After completion of the reaction, the reaction mixture was cooled to room temperature, and the precipitated solid was filtered and washed with water and ethyl acetate. The filtered solid was diluted with ethyl acetate, warmed and slurred for about 1 hour, cooled to room temperature and filtered. 27 g (78%) of a white solid was obtained.
(반응예 3-2) 화합물 3의 합성(Reaction Example 3-2) Synthesis of
2-(3-(2-클로로디벤조[b,d]퓨란-4-일)페닐)-4,6-디페닐-1,3,5-트리아진 (10g, 19.6mmol)과 (9-페닐-9H-카바졸-3-일)보론산 (5.9g, 20.6mmol)을 디옥산 100mL에 투입한 후, 포타슘카보네이트 8.3 g(58.8mmol)을 녹인 수용액 20mL를 반응물에 첨가하여 가온하였다. 환류 상태에서 트리시클로헥실포스핀 350 mg(1.23mmol)과 비스(디벤질리딘아세톤)팔라듐(0) 350mg (0.61mmol)을 디옥산 5mL에 혼합하여 녹인 후 환류 상태의 혼합물에 첨가하였다. 반응이 완결되면 실온으로 냉각하고 에틸아세테이트로 추출하여 물로 2회 세척하고, 유기층을 모아서 무수황산마그네슘으로 처리하여 여과하였다. 감압하에 농축하고 석출된 고체를 여과하였다. 여과한 고체를 다시 클로로포름에 녹인 후 환류하에 용매를 제거하면서 에틸아세테이트로 재결정하여 흰색의 목적화합물 3을 10g(68%) 얻었다. MS: [M+H]+ = 717Phenyl-4,6-diphenyl-1,3,5-triazine (10 g, 19.6 mmol) and (9- Phenyl-9H-carbazol-3-yl) boronic acid (5.9 g, 20.6 mmol) was added to 100 mL of dioxane and then 20 mL of an aqueous solution containing 8.3 g (58.8 mmol) of potassium carbonate was added to the reaction mixture. 350 mg (1.23 mmol) of tricyclohexylphosphine and 350 mg (0.61 mmol) of bis (dibenzylidineacetone) palladium (0) were mixed and dissolved in dioxane (5 mL) at reflux and then added to the refluxed mixture. When the reaction was completed, the reaction mixture was cooled to room temperature, extracted with ethyl acetate, washed twice with water, and the organic layer was collected, treated with anhydrous magnesium sulfate and filtered. The filtrate was concentrated under reduced pressure and the precipitated solid was filtered. The filtered solid was redissolved in chloroform, and the solvent was removed under reflux, and recrystallization from ethyl acetate gave 10 g (68%) of the
제조예 3의 제조방법에 따라 화합물 4 내지 14를 제조하였다.
(%)Yield
(%)
[M+H]MS
[M + H] <
4
(화합물4)Manufacturing example
4
(Compound 4)
5
(화합물5)Manufacturing example
5
(Compound 5)
6
(화합물6)Manufacturing example
6
(Compound 6)
7
(화합물7)Manufacturing example
7
(Compound 7)
(화합물8)Production Example 8
(Compound 8)
9
(화합물9)Manufacturing example
9
(Compound 9)
10
(화합물10)Manufacturing example
10
(Compound 10)
11
(화합물11)Manufacturing example
11
(Compound 11)
12
(화합물12)Manufacturing example
12
(Compound 12)
13
(화합물13)Manufacturing example
13
(Compound 13)
14
(화합물14)Manufacturing example
14
(Compound 14)
<< 제조예Manufacturing example 15> 화합물 15의 합성 15> Synthesis of Compound 15
(반응예 15-1) 2-(2-클로로디벤조[b,d]퓨란-4-yl)-4,4,5,5-테트라메틸-1,3,2-디옥사보롤란의 합성(Reaction Example 15-1) Synthesis of 2- (2-chlorodibenzo [b, d] furan-4-yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane
화합물 1 15 g(0.05mol)을 1,4-다이옥산 180mL에 녹인 후 비스(피나콜라토)디보론 16g(0.06mol)을 투입하였다. 혼합물을 교반 하면서 포타슘아세테이트 15.6 g(0.16 mol)를 첨가하고 가온 하여 환류 시켰다. 환류 교반 상태에서 디벤질리덴아세톤팔라듐 900 mg(0.001mol) 과 트리시클로헥실포스핀 890mg(0.003mol)을 첨가하고 24시간 환류 교반시켰다. 반응 종결 후 반응물을 실온으로 냉각하여 물로 세척 후 에틸아세테이트로 2회 추출하였다. 모아진 유기층을 다시 한번 물로 세척 후 무수황산마그네슘으로 수분을 제거하고 여과하여 농축하였다. 농축한 물질을 에틸아세테이트와 헥산의 혼합용액으로 가열 교반 하고 여과하여 목적화합물 15.7 g(90%)을 얻었다.15 g (0.05 mol) of
(반응예 15-2) 2-(2-클로로디벤조[b,d]퓨란-4-일)-4,6-디페닐-1,3,5-트리아진의 합성(Reaction Example 15-2) Synthesis of 2- (2-chlorodibenzo [b, d] furan-4-yl) -4,6-diphenyl-1,3,5-triazine
2-(2-클로로디벤조[b,d]퓨란-4-일)-4,4,5,5-테트라메딜-1,3,2-디옥사보롤란 11.5g(0.035mol)과 2-클로로-4,6-디페닐-1,3,5-트리아진 10.3 g(0.037mol)을 THF(테트라하이드로퓨란(Tetrahydrofuran)) 100mL에 녹이고, 14.5g(0.10 mol)의 포타슘카보네이트를 녹인 수용액 20mL를 반응물에 첨가하여 가온하였다. 환류 상태에서 테트라키스(트리페닐포스핀)팔라듐(0) 400 mg (0.35 mmol)을 투입하였다. 혼합물을 12시간 동안 환류 교반 시켰다. 반응 종결 후 실온으로 냉각하여 석출된 고체를 여과하고 물과 에틸아세테이트로 씻어 주었다. 여과된 고체를 에틸아세테이트에 희석한 후 가온하여 1시간 정도 슬러리 시키고, 실온으로 냉각하여 여과하였다. 흰색의 고체 11.8g(78%)을 얻었다. (0.035 mol) of 2- (2-chlorodibenzo [b, d] furan-4-yl) -4,4,5,5-tetramethyl- 10.0 g (0.037 mol) of chloro-4,6-diphenyl-1,3,5-triazine was dissolved in 100 mL of THF (tetrahydrofuran), 20 mL of an aqueous solution containing 14.5 g (0.10 mol) of potassium carbonate Was added to the reaction mixture and the mixture was warmed. 400 mg (0.35 mmol) of tetrakis (triphenylphosphine) palladium (0) was added thereto under reflux. The mixture was refluxed for 12 hours. After completion of the reaction, the reaction mixture was cooled to room temperature, and the precipitated solid was filtered and washed with water and ethyl acetate. The filtered solid was diluted with ethyl acetate, warmed and slurred for about 1 hour, cooled to room temperature and filtered. 11.8 g (78%) of a white solid was obtained.
(반응예 15-3) 화합물 15의 합성(Reaction Example 15-3) Synthesis of Compound 15
2-(2-클로로디벤조[b,d]퓨란-4-일)-4,6-디페닐-1,3,5-트리아진 (10.0g, 23.0mmol)과 (9-페닐-9H-카바졸-3-일)보론산 (7.2g, 25.3mmol)을 디옥산 100mL에 투입한 후, 포타슘카보네이트 9.7 g(68.7mmol)을 녹인 수용액 20mL를 반응물에 첨가하여 가온하였다. 환류 상태에서 트리시클로헥실포스핀 400 mg(1.43mmol)과 비스(디벤질리딘아세톤)팔라듐(0) 400mg (0.71mmol)을 dioxane 5mL에 혼합하여 녹인 후 환류 상태의 혼합물에 첨가한다. 반응이 완결되면 용매를 감압하에 농축한 후 클로로포름에 희석하여 물로 2회 세척하고, 유기층을 모아서 무수황산마그네슘과 산성백토로 처리하여 여과하였다. 에틸아세테이트를 첨가하여 환류하에 재결정하여 흰색의 목적화합물 15를 10.3g(70%) 얻었다. MS: [M+H]+ = 641(10.0 g, 23.0 mmol) and (9-phenyl-9H-benzo [b, d] furan- 3-yl) boronic acid (7.2 g, 25.3 mmol) was added to 100 mL of dioxane, and 20 mL of an aqueous solution containing 9.7 g (68.7 mmol) of potassium carbonate was added to the reaction mixture and the mixture was warmed. 400 mg (1.43 mmol) of tricyclohexylphosphine and 400 mg (0.71 mmol) of bis (dibenzylidineacetone) palladium (0) were mixed and dissolved in dioxane (5 mL) at reflux and then added to the refluxed mixture. When the reaction was completed, the solvent was concentrated under reduced pressure, diluted with chloroform and washed twice with water. The organic layer was collected, treated with anhydrous magnesium sulfate and acidic white clay, and filtered. Ethyl acetate was added and the mixture was recrystallized under reflux to obtain 10.3 g (70%) of the target compound 15 as white. MS: [M + H] < + > = 641
제조예 15의 제조방법에 따라 화합물 16 내지 35를 제조하였다.Compounds 16 to 35 were prepared according to the preparation method of Preparation Example 15.
(%)Yield
(%)
[M+H]MS
[M + H] <
16
(화합물16)Manufacturing example
16
(Compound 16)
17
(화합물17)Manufacturing example
17
(Compound 17)
18
(화합물18)Manufacturing example
18
(Compound 18)
19
(화합물19)Manufacturing example
19
(Compound 19)
20
(화합물20)Manufacturing example
20
(Compound 20)
21
(화합물21)Manufacturing example
21
(Compound 21)
22
(화합물22)Manufacturing example
22
(Compound 22)
23
(화합물23)Manufacturing example
23
(Compound 23)
24
(화합물24)Manufacturing example
24
(Compound 24)
25
(화합물25)Manufacturing example
25
(Compound 25)
26
(화합물26)Manufacturing example
26
(Compound 26)
27
(화합물27)Manufacturing example
27
(Compound 27)
28
(화합물28)Manufacturing example
28
(Compound 28)
29
(화합물29)Manufacturing example
29
(Compound 29)
30
(화합물30)Manufacturing example
30
(Compound 30)
31
(화합물31)Manufacturing example
31
(Compound 31)
32
(화합물32)Manufacturing example
32
(Compound 32)
33
(화합물33)Manufacturing example
33
(Compound 33)
34
(화합물34)Manufacturing example
34
(Compound 34)
35
(화합물35)Manufacturing example
35
(Compound 35)
<< 제조예Manufacturing example 36> 화합물 36의 합성 36> Synthesis of Compound 36
반응예 36-1) 2-(3-(2-클로로디벤조[b,d]퓨란-4-일)페닐)-4,6-디페닐-1,3,5-트리아진의 합성Reaction Example 36-1 Synthesis of 2- (3- (2-chlorodibenzo [b, d] furan-4-yl) phenyl) -4,6-diphenyl-1,3,5-triazine
제조예 3의 반응예 1의 제조와 동일한 방법으로 4-브로모-2-클로로디벤조[b,d]퓨란 10g(0.035mol)을 반응하여 목적화합물 2-(3-(2-클로로디벤조[b,d]퓨란-4-yl)페닐)-4,6-디페닐-1,3,5-트리아진 14.4g(81%)을 얻었다. (0.035 mol) of 4-bromo-2-chlorodibenzo [b, d] furan was reacted in the same manner as in the preparation of Reaction Example 1 of Preparation Example 3 to obtain the desired compound 2- (3- [b, d] furan-4-yl) phenyl) -4,6-diphenyl-1,3,5-triazine (81%).
반응예 36- 2) 화합물 33의 합성Reaction Example 36-2) Synthesis of Compound 33
2-(3-(2-클로로디벤조[b,d]퓨란-4-일)페닐)-4,6-디페닐-1,3,5-트리아진 (10g, 19.6mmol)과 9H-카바졸 (3.6g, 20.6mmol)을 자일렌 100mL에 투입한 후, 나트륨 터트-부톡사이드 3.8 g(39.2mmol)을 반응물에 첨가하여 가온하였다. 환류 상태에서 비스(트리터트-부틸포스핀)팔라듐 100mg (0.2mmol)을 투입하여 6시간 교반하였다. 반응이 완결되면 실온으로 냉각하고 석출된 고체를 여과하여 에틸아세테이트로 씻어준 후 여과한 고체를 다시 클로로포름에 녹인 후 물로 2회 세척하고, 유기층을 모아서 무수황산마그네슘과 산성백토로 처리하여 여과하였다. 여과한 용액을 가온하여 에틸아세테이트로 재결정하여 흰색의 목적화합물 33을 9.4 g(75%) 얻었다. Phenyl) -4,6-diphenyl-1,3,5-triazine (10 g, 19.6 mmol) and 9H-carbazole The sol (3.6 g, 20.6 mmol) was added to 100 mL of xylene, and 3.8 g (39.2 mmol) of sodium tert-butoxide was added to the reaction mixture and the mixture was warmed. 100 mg (0.2 mmol) of bis (tri-tert-butylphosphine) palladium was added under reflux and stirred for 6 hours. When the reaction was completed, the reaction mixture was cooled to room temperature. The precipitated solid was filtered and washed with ethyl acetate. The solid filtered again was washed with chloroform and washed twice with water. The organic layer was collected and treated with anhydrous magnesium sulfate and acidic white clay. The filtered solution was warmed and recrystallized from ethyl acetate to obtain 9.4 g (75%) of the title compound 33 as a white solid.
제조예 36의 제조방법에 따라 화합물 37 내지 41 를 제조하였다.Compounds 37 to 41 were prepared according to the preparation method of Preparation 36.
(%)Yield
(%)
[M+H]MS
[M + H] <
37
(화합물37)Manufacturing example
37
(Compound 37)
38
(화합물38)Manufacturing example
38
(Compound 38)
39
(화합물39)Manufacturing example
39
(Compound 39)
40
(화합물40)Manufacturing example
40
(Compound 40)
41
(화합물41)Manufacturing example
41
(Compound 41)
<< 제조예Manufacturing example 42> 화합물 42의 합성 42> Synthesis of Compound 42
반응예 42-1) 3-클로로-1-(3-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)-9H-카바졸의 합성Reaction Example 42-1 Synthesis of 3-chloro-1- (3- (4,6-diphenyl-1,3,5-triazin-2-yl) phenyl) -9H-carbazole
화합물 1-브로모-3-클로로-9H-카바졸 15 g(0.053mol)과 2,4-디페닐-6-(3-(4,4,5,5-데트라메틸-1,3,2-디옥사보롤란-2-일)페닐)-1,3,5-트리아진 25.6g (0.06mol)을 THF(테트라하이드로퓨란(Tetrahydrofuran)) 150mL에 녹이고, 22g(0.16 mol)의 포타슘카보네이트를 30 mL의 물에 녹인 수용액을 반응물에 첨가하여 가온하였다. 환류 상태에서 테트라키스(트리페닐포스핀)팔라듐(0) 620 mg (0.5 mmol)을 투입하였다. 혼합물을 12시간 동안 환류 교반 시켰다. 반응 종결 후 실온으로 냉각하여 석출된 고체를 여과하고 물과 에틸아세테이트로 씻어 주었다. 여과된 고체를 에틸아세테이트에 희석한 후 가온하여 1시간 정도 슬러리 시키고, 실온으로 냉각하고 여과하여 엷은 노란색의 목적화합물 3-클로로-1-(3-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)-9H-카바졸 20 g(75%)을 얻었다. A mixture of 15 g (0.053 mol) of 1-bromo-3-chloro-9H-carbazole and 2,4-diphenyl-6- (3- (4,4,5,5-tetramethyl- Dioxaborolan-2-yl) phenyl) -1,3,5-triazine was dissolved in 150 mL of THF (tetrahydrofuran), 22 g (0.16 mol) of potassium carbonate In 30 mL of water was added to the reaction solution, followed by heating. 620 mg (0.5 mmol) of tetrakis (triphenylphosphine) palladium (0) was added under reflux. The mixture was refluxed for 12 hours. After completion of the reaction, the reaction mixture was cooled to room temperature, and the precipitated solid was filtered and washed with water and ethyl acetate. The filtrate was diluted with ethyl acetate and heated to a slurry for about 1 hour. The mixture was cooled to room temperature and filtered to obtain the objective compound 3-chloro-1- (3- (4,6-diphenyl- 5-triazin-2-yl) phenyl) -9H-carbazole (20 g, 75%).
반응예 42-2) 3-클로로-1-(3-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)-9-페닐-9H-카바졸의 합성Reaction Example 42-2 Synthesis of 3-chloro-1- (3- (4,6-diphenyl-1,3,5-triazin-2-yl) phenyl) -9-phenyl-9H-
3-클로로-1-(3-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)-9H-카바졸 20 g (39.2mmol)에 요오도벤젠 40 g(196mmol)과 세슘카보네이트 25 g(78mmol)을 투입하여 가온한 후, 환류 상태의 혼합물에 CuI(1.5g, 7.85mmol)와 1,10-페난트롤린 (1.4g, 7.84mmol)을 각각 투입하여 교반시켰다. 반응이 완결되면 혼합물을 감압증류하여 잔류하는 요오도벤젠을 제거하고 실온으로 식힌 후 클로로포름에 녹여서 물로 3번 씻어준 후 유기층을 모아서 무수황산마그네슘으로 처리하여 여과 후 감압 농축하였다. 농축한 화합물에 에틸아세테이트를 넣고 슬러리 후 여과하여 엷은 노란색의 목적화합물 3-클로로-1-(3-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)-9-페닐-9H-카바졸 16.2 g(71%)을 얻었다.20 g (39.2 mmol) of 3-chloro-1- (3- (4,6-diphenyl-1,3,5-triazin- (1.5 g, 7.85 mmol) and 1,10-phenanthroline (1.4 g, 7.84 mmol) were added to the refluxed mixture, followed by stirring . After the reaction was completed, the mixture was distilled under reduced pressure to remove residual iodobenzene. The mixture was cooled to room temperature, dissolved in chloroform and washed three times with water. The organic layer was collected, treated with anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. Ethyl acetate was added to the concentrated compound, followed by slurrying and filtration to obtain the desired compound 3-chloro-1- (3- (4,6-diphenyl-1,3,5-triazin- 9-phenyl-9H-carbazole (16.2 g, 71%).
반응예 42-3) 화합물 42의 합성Reaction Example 42-3) Synthesis of Compound 42
3-클로로-1-(3-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)-9-페닐-9H-카바졸 (15g, 25.6mmol)과 9H-카바졸 (4.7g, 28.1mmol)을 자일렌 150mL에 투입한 후, 나트륨 터트-부톡사이드 5.0 g(51.2mmol)을 반응물에 첨가하여 가온하였다. 환류 상태에서 비스(트리터트-부틸포스핀)팔라듐 130mg (0.3mmol)을 투입하여 6시간 교반하였다. 반응이 완결되면 실온으로 냉각하고 석출된 고체를 여과하여 에틸아세테이트로 씻어준 후 여과한 고체를 다시 클로로포름에 녹인 후 물로 2회 세척하고, 유기층을 모아서 무수황산마그네슘과 산성백토로 처리하여 여과하였다. 여과한 용액을 가온하여 에틸아세테이트로 재결정하여 흰색의 목적화합물 42을 11.5 g(63%) 얻었다9-phenyl-9H-carbazole (15 g, 25.6 mmol) and 9H-pyrazolo [3,4- Carbazole (4.7 g, 28.1 mmol) was added to 150 mL of xylene, and then 5.0 g (51.2 mmol) of sodium tert-butoxide was added to the reaction mixture and the mixture was warmed. 130 mg (0.3 mmol) of bis (tri-tert-butylphosphine) palladium was added under reflux and stirred for 6 hours. When the reaction was completed, the reaction mixture was cooled to room temperature. The precipitated solid was filtered and washed with ethyl acetate. The solid filtered again was washed with chloroform and washed twice with water. The organic layer was collected and treated with anhydrous magnesium sulfate and acidic white clay. The filtered solution was warmed and recrystallized with ethyl acetate to obtain 11.5 g (63%) of the target compound 42 as white
제조예 42의 제조방법에 따라 화합물 43 내지 46을 제조하였다.Compounds 43 to 46 were prepared according to the preparation method of Preparation 42.
(%)Yield
(%)
[M+H]MS
[M + H] <
43
(화합물43)Manufacturing example
43
(Compound 43)
44
(화합물44)Manufacturing example
44
(Compound 44)
45
(화합물45)Manufacturing example
45
(Compound 45)
46
(화합물46)Manufacturing example
46
(Compound 46)
<< 제조예Manufacturing example 47> 화합물 47의 합성 47> Synthesis of Compound 47
반응예 1) 화합물 47의 합성Reaction Example 1) Synthesis of Compound 47
제조예 42의 반응예 42-2에서 합성한 3-클로로-1-(3-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)-9H-카바졸 14 g(23.9mmol)과 (9-페닐-9H-카바졸-3-일)보론산 (7.2g, 25.3mmol)을 디옥산 120mL에 투입한 후, 포타슘카보네이트 9.7 g(68.7mmol)을 수용액 30mL에 녹여 반응물에 첨가하여 가온하였다. 환류 상태에서 트리시클로헥실포스핀 400 mg(1.43mmol)과 비스(디벤질리딘아세톤)팔라듐(0) 400mg (0.71mmol)을 디옥산 5mL에 혼합하여 녹인 후 환류 상태의 혼합물에 첨가하였다. 반응이 완결되면 용매를 감압하에 농축한 후 클로로포름에 희석하여 물로 2회 세척하고, 유기층을 모아서 무수황산마그네슘과 산성백토로 처리하여 여과하였다. 에틸아세테이트를 첨가하여 환류하에 재결정하여 흰색의 목적화합물 47를 13.8g(73%) 얻었다. Synthesis of 3-chloro-1- (3- (4,6-diphenyl-1,3,5-triazin-2-yl) phenyl) -9H-carbazole 14 (7.2 g, 25.3 mmol) was added to 120 mL of dioxane, and then 9.7 g (68.7 mmol) of potassium carbonate was added to 30 mL of an aqueous solution The reaction mixture was warmed by adding thereto. 400 mg (1.43 mmol) of tricyclohexylphosphine and 400 mg (0.71 mmol) of bis (dibenzylidineacetone) palladium (0) were mixed and dissolved in dioxane (5 mL) at reflux and then added to the refluxed mixture. When the reaction was completed, the solvent was concentrated under reduced pressure, diluted with chloroform and washed twice with water. The organic layer was collected, treated with anhydrous magnesium sulfate and acidic white clay, and filtered. Ethyl acetate was added and the mixture was recrystallized under reflux to obtain 13.8 g (73%) of the target compound 47 as white.
제조예 47의 제조방법에 따라 화합물 48 내지 52를 제조하였다.Compounds 48 to 52 were prepared according to the preparation method of Preparation 47.
(%)Yield
(%)
[M+H]MS
[M + H] <
48
(화합물48)Manufacturing example
48
(Compound 48)
49
(화합물49)Manufacturing example
49
(Compound 49)
50
(화합물50)Manufacturing example
50
(Compound 50)
51
(화합물51)Manufacturing example
51
(Compound 51)
52
(화합물52)Manufacturing example
52
(Compound 52)
<< 제조예Manufacturing example 53> 화합물 53의 합성 53> Synthesis of Compound 53
반응예 53-1) 3-(2-클로로디벤조[b,d]퓨란-4-일)-9-페닐-9H-카바졸의 합성Reaction Example 53-1) Synthesis of 3- (2-chlorodibenzo [b, d] furan-4-yl) -9-phenyl-9H-
제조예 3의 반응예 1의 제조예와 동일한 방법으로, 4-디페닐-6-(3-(4,4,5,5-테트라메틸-1,3,2-디옥사보롤란-2-yl)페닐)-1,3,5-트리아진 대신에 (9-페닐-9H-카바졸-3-yl)보론산를 동일한 당량으로 사용하여 흰색의 목적화합물 3-(2-클로로디벤조[b,d]퓨란-4-일)-9-페닐-9H-카바졸 12.3 g(79%)을 얻었다. In the same manner as in Production Example 1 of Production Example 3, 4-diphenyl-6- (3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan- (9-phenyl-9H-carbazol-3-yl) boronic acid was used in the same manner as the preparation of the objective compound 3- (2-chlorodibenzo [b , d] furan-4-yl) -9-phenyl-9H-carbazole (12.3 g, 79%).
반응예 53-2) 화합물 53의 합성Reaction Example 53-2) Synthesis of Compound 53
3-(2-클로로디벤조[b,d]퓨란-4-yl)-9-페닐-9H-카바졸 10 g(22.5mmol)과 2,4-디페닐-6-(3-(4,4,5,5-테트라메틸-1,3,2-디옥사보롤란-2-일)페닐)-1,3,5-트리아진 10.7 g(24.7mmol)을 출발물질로 하여 제조예 3의 반응예 2와 동일한 방법으로 제조하여 흰색의 목적화합물 53을 12.3 g(77%) 얻었다. A mixture of 10 g (22.5 mmol) of 3- (2-chlorodibenzo [b, d] furan-4-yl) 2-yl) phenyl) -1,3,5-triazine (10.7 g, 24.7 mmol) as starting materials in the same manner as in Production Example 3 Was prepared in the same manner as in Reaction Example 2 to obtain 12.3 g (77%) of the desired compound 53 as white.
제조예 53의 제조방법에 따라 화합물 54 내지 58을 제조하였다.Compounds 54 to 58 were prepared according to the preparation method of Preparation 53.
(%)Yield
(%)
[M+H]MS
[M + H] <
(화합물54)Production example 54
(Compound 54)
55
(화합물55)Manufacturing example
55
(Compound 55)
56
(화합물56)Manufacturing example
56
(Compound 56)
57
(화합물57)Manufacturing example
57
(Compound 57)
58
(화합물58)Manufacturing example
58
(Compound 58)
<< 제조예Manufacturing example 59> 화합물 59의 합성 59> Synthesis of Compound 59
반응예 59-1) 1-(4-(9H-카바졸-9-yl)페닐)-3-클로로-9H-카바졸의 합성Reaction Example 59-1) Synthesis of 1- (4- (9H-carbazol-9-yl) phenyl) -3-chloro-9H-
화합물 1-브로모-3-클로로-9H-카바졸(15g, 0.053mol)과 9-(4-(4,4,5,5-테트라메틸-1,3,2-디옥사보롤란-2-일)페닐)-9H-카바졸 (21.4 g, 0.058mol)을 출발물질하여 제조예 42의 반응예 1과 동일한 방법으로 제조하여 흰색의 목적화합물 1-(4-(9H-카바졸-9-일)페닐)-3-클로로-9H-카바졸 21 g(89%)을 얻었다. The compound 1-Bromo-3-chloro-9H-carbazole (15 g, 0.053 mol) and 9- (4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan- -9-phenyl) -9H-carbazole (21.4 g, 0.058 mol) as a starting material was prepared in the same manner as in Production Example 42, Yl) phenyl) -3-chloro-9H-carbazole (21 g, 89%).
반응예 59-2) 1-(4-(9H-카바졸-9-일)페닐)-3-(4,4,5,5-테트라메틸-1,3,2-디옥사보롤란-2-일)-9H-카바졸의 합성Reaction Example 59-2) 1- (4- (9H-Carbazol-9-yl) phenyl) -3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan- -Yl) -9H-carbazole < / RTI >
1-(4-(9H-카바졸-9-yl)페닐)-3-클로로-9H-카바졸 (10 g, 22.5mmol)을 출발물질로 하여 제조예 15의 반응예 1과 동일한 방법으로 제조하여 흰색의 목적화합물 1-(4-(9H-카바졸-9-일)페닐)-3-(4,4,5,5-테트라메틸-1,3,2-디옥사보롤란-2-일)-9H-카바졸 10.9 g(91%)을 얻었다. Prepared by the same method as in the reaction example 1 of preparation 15, using the starting material of 1- (4- (9H-carbazol-9-yl) phenyl) -3-chloro-9H-carbazole To give the desired compound 1- (4- (9H-carbazol-9-yl) phenyl) -3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan- Yl) -9H-carbazole (10.9 g, 91%).
반응예 59-3) 1-(4-(9H-카바졸-9-일)페닐)-3-(4,6-디페닐-1,3,5-트리아진-2-일)-9H-카바졸의 합성Reaction Example 59-3) Synthesis of 1- (4- (9H-carbazol-9-yl) phenyl) -3- (4,6-diphenyl-1,3,5-triazin- Synthesis of carbazole
1-(4-(9H-카바졸-9-일)페닐)-3-(4,4,5,5-테트라메틸-1,3,2-디옥사보롤란-2-일)-9H-카바졸 (12 g, 22.4mmol)을 출발물질로 하여 제조예 15의 반응예 2와 동일한 방법으로 제조하여 흰색의 목적화합물 1-(4-(9H-카바졸-9-일)페닐)-3-(4,6-디페닐-1,3,5-트리아진-2-일)-9H-카바졸 12.9 g(90%)을 얻었다.(4- (9H-carbazol-9-yl) phenyl) -3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan- Carbazole (12 g, 22.4 mmol) as a starting material, the objective compound 1- (4- (9H-carbazol-9-yl) phenyl) -3 - (4,6-diphenyl-1,3,5-triazin-2-yl) -9H-carbazole was obtained in an amount of 12.9 g (90%).
반응예 59-4) 화합물 59의 합성 Reaction Example 59-4) Synthesis of Compound 59
화합물 1-(4-(9H-카바졸-9-일)페닐)-3-(4,6-디페닐-1,3,5-트리아진-2-일)-9H-카바졸 (15 g, 24.4mmol)을 출발물질로 하여 제조예 42의 반응예 2와 동일한 방법으로 제조하여 흰색의 목적화합물 59를 14.7 g(85%) 얻었다. The compound 1- (4- (9H-carbazol-9-yl) phenyl) -3- (4,6-diphenyl-1,3,5-triazin- , 24.4 mmol) as a starting material, and 14.7 g (85%) of the target compound 59 as a white compound were obtained.
제조예 59의 제조방법에 따라 화합물 60 내지 63을 제조하였다.Compounds 60 to 63 were prepared according to the preparation method of Preparation 59.
(%)Yield
(%)
[M+H]MS
[M + H] <
60
(화합물60)Manufacturing example
60
(Compound 60)
61
(화합물61)Manufacturing example
61
(Compound 61)
62
(화합물62)Manufacturing example
62
(Compound 62)
63
(화합물63)Manufacturing example
63
(Compound 63)
<< 제조예Manufacturing example 64> 화합물 64의 합성 64> Synthesis of Compound 64
반응예 64-1) 2-메톡시카보닐-3'-브로모-5'-클로로바이페닐의 합성Reaction Example 64-1) Synthesis of 2-methoxycarbonyl-3'-bromo-5'-chlorobiphenyl
제조예 1의 반응예 1-1의 제조와 동일한 방법으로 1,3-다이브로모-5-클로로벤젠 50g(0.18mol)과 2-(메톡시카보닐)페닐보론산 34g(0.18mol)을 톨루엔과 메탄올을 용매로 반응하여 목적화합물 2-메톡시카보닐-3'-브로모-5'-클로로바이페닐 51g(86%)을 얻었다. (0.18 mol) of 1,3-dibromo-5-chlorobenzene and 34 g (0.18 mol) of 2- (methoxycarbonyl) phenylboronic acid were dissolved in toluene And methanol were reacted with a solvent to obtain 51 g (86%) of 2-methoxycarbonyl-3'-bromo-5'-chlorobiphenyl as a target compound.
반응예 64-2) 2-(3'-브로모-5'-클로로바이페닐-2-일)프로판-2-올의 합성Reaction Example 64-2) Synthesis of 2- (3'-bromo-5'-chlorobiphenyl-2-yl) propan-
2-메톡시카보닐-3'-브로모-5'-클로로바이페닐 50g(0.15mol)을 THF에 녹이고, THF에 3M로 희석된 메틸마그네슘브로마이드 100mL를 천천히 적가한다. 반응물을 60℃로 가온하여 12시간 교반한다. 반응 완결 후 실온으로 냉각하고 물로 세척 후 에틸아세테이트로 추출하고 무수황산마그네슘으로 건조하여 여과 후 감압 농축한다. 에틸아세테이트와 헥산으로 재결정하여 목적화합물 2-(3'-브로모-5'-클로로바이페닐-2-일)프로판-2-올 38g(76%)을 얻었다. 50 g (0.15 mol) of 2-methoxycarbonyl-3'-bromo-5'-chlorobiphenyl are dissolved in THF, and 100 ml of methylmagnesium bromide diluted with 3 M in THF is slowly added dropwise. The reaction was warmed to 60 占 폚 and stirred for 12 hours. After completion of the reaction, the reaction mixture was cooled to room temperature, washed with water, extracted with ethyl acetate, dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. The residue was recrystallized from ethyl acetate and hexane to obtain 38 g (76%) of the desired compound 2- (3'-bromo-5'-chlorobiphenyl-2-yl) propan-2-ol.
반응예 64-3) 1-브로모-3-클로로-9,9-디메틸-9H-플루오렌의 합성Reaction Example 64-3) Synthesis of 1-bromo-3-chloro-9,9-dimethyl-9H-fluorene
2-(3'-브로모-5'-클로로바이페닐-2-일)프로판-2-올 38g(0.12mol)을 아세트산 200mL와 인산 50mL에 녹이고, 120℃로 가온하여 12시간 교반한다. 반응이 완결되면 실온으로 냉각하여 석출된 고체를 여과하고, 여과한 고체는 에탄올에 희석하고 NaHCO3 수용액으로 씻어준 후 여과하여 목적화합물 1-브로모-3-클로로-9,9-디메틸-9H-플루오렌 20g(56%)을 얻었다. 38 g (0.12 mol) of 2- (3'-bromo-5'-chlorobiphenyl-2-yl) propan-2-ol was dissolved in 200 mL of acetic acid and 50 mL of phosphoric acid, and the mixture was heated to 120 ° C and stirred for 12 hours. When the reaction was completed, the reaction mixture was cooled to room temperature, and the precipitated solid was filtered. The filtered solid was diluted with ethanol, washed with an aqueous solution of NaHCO 3 and then filtered to obtain the desired compound 1-bromo-3-chloro-9,9- -Fluorene (56%).
반응예 64-4) 2-(3-클로로-9,9-디메틸-9H-플루오렌-1-일)-4,4,5,5-테트라메틸-1,3,2-디옥사보롤란의 합성Reaction Example 64-4) Synthesis of 2- (3-chloro-9,9-dimethyl-9H-fluoren-1-yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane Synthesis of
제조예 15의 반응예 15-1의 제조와 동일한 방법으로 1-브로모-3-클로로-9,9-디메틸-9H-플루오렌 20g(0.065mol)을 반응하여 목적화합물 2-(3-클로로-9,9-디메틸-9H-플루오렌-1-일)-4,4,5,5-테트라메틸-1,3,2-디옥사보롤란 16.8g(73%)을 얻었다. (0.065 mol) of 1-bromo-3-chloro-9,9-dimethyl-9H-fluorene was reacted in the same manner as in the preparation of Reaction Example 15-1 of Preparation Example 15 to obtain the target compound 2- -9,9-dimethyl-9H-fluoren-1-yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane was obtained in an amount of 16.8 g (73%).
반응예 64-5) 2-(3-클로로-9,9-디메틸-9H-플루오렌-1-일)-4,6-디페닐-1,3,5-트리아진의 합성Reaction Example 64-5) Synthesis of 2- (3-chloro-9,9-dimethyl-9H-fluoren-1-yl) -4,6-diphenyl-1,3,5-triazine
제조예 15의 반응예 15-2의 제조와 동일한 방법으로 2-(3-클로로-9,9-디메틸-9H-플루오렌-1-일)-4,4,5,5-테트라메틸-1,3,2-디옥사보롤란 15g(0.042mol)과 2-클로로-4,6-디페닐-1,3,5-트리아진 11.3g(0.042mol)을 반응하여 목적화합물 (3-클로로-9,9-디메틸-9H-플루오렌-1-일)-4,6-디페닐-1,3,5-트리아진 15.7g(81%)을 얻었다. (3-chloro-9,9-dimethyl-9H-fluoren-1-yl) -4,4,5,5-tetramethyl- (0.042 mol) of 3,2-dioxaborolane and 11.3 g (0.042 mol) of 2-chloro-4,6-diphenyl-1,3,5-triazine were reacted to obtain the desired compound (3-chloro- 9,9-dimethyl-9H-fluoren-1-yl) -4,6-diphenyl-1,3,5-triazine (81%).
반응예 64-6) 화합물 64의 합성 Reaction Example 64-6) Synthesis of Compound 64
제조예 15의 반응예 15-3의 제조와 동일한 방법으로 (3-클로로-9,9-디메틸-9H-플루오렌-1-일)-4,6-디페닐-1,3,5-트리아진 15g(0.032mol)과 9-페닐-2-(4,4,5,5-테트라메틸-1,3,2-디옥사보롤란-2-일)-9H-카바졸 12.4g(0.032mol)을 반응하여 흰색의 목적화합물 64를 15.2g(70%) 얻었다. MS: [M+H]+ = 667.8(3-chloro-9,9-dimethyl-9H-fluoren-1-yl) -4,6-diphenyl-1,3,5-tri (0.032 mol) of azine and 12.4 g (0.032 mol) of 9-phenyl-2- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan- ) To obtain 15.2 g (70%) of the desired compound 64 as white. MS: [M + H] < + > = 667.8
<< 실험예Experimental Example 1> 1>
ITO(indium tin oxide)가 1,500 Å의 두께로 박막 코팅된 유리 기판을 세제를 녹인 증류수에 넣고 초음파로 세척하였다. 이때, 세제로는 피셔사(Fischer Co.) 제품을 사용하였으며, 증류수로는 밀리포어사(Millipore Co.) 제품의 필터(Filter)로 2차로 걸러진 증류수를 사용하였다. ITO를 30분간 세척한 후 증류수로 2회 반복하여 초음파 세척을 10분간 진행하였다. 증류수 세척이 끝난 후, 이소프로필알콜, 아세톤, 메탄올의 용제로 초음파 세척을 하고 건조시킨 후 플라즈마 세정기로 수송시켰다. 또한, 산소 플라즈마를 이용하여 상기 기판을 5분간 세정한 후 진공 증착기로 기판을 수송시켰다.The glass substrate coated with ITO (indium tin oxide) film with a thickness of 1,500 Å was immersed in distilled water containing detergent and washed with ultrasonic waves. At this time, a Fischer Co. product was used as a detergent, and distilled water, which was filtered with a filter of Millipore Co., was used as distilled water. The ITO was washed for 30 minutes and then washed twice with distilled water and ultrasonically cleaned for 10 minutes. After the distilled water was washed, it was ultrasonically washed with a solvent of isopropyl alcohol, acetone, and methanol, dried, and then transported to a plasma cleaner. Further, the substrate was cleaned using oxygen plasma for 5 minutes, and then the substrate was transported by a vacuum evaporator.
이렇게 준비된 ITO 투명 전극 위에 하기 화학식의 헥사니트릴 헥사아자트리페닐렌(hexanitrile hexaazatriphenylene; HAT)를 500Å의 두께로 열 진공 증착하여 정공 주입층을 형성하였다.Hexanitrile hexaazatriphenylene (HAT) of the following chemical formula was thermally vacuum deposited on the prepared ITO transparent electrode to a thickness of 500 Å to form a hole injection layer.
[HAT][LINE]
상기 정공 주입층 위에 하기 구조의 NPB(N, N-Bis-(1-naphthalenyl)-N, N-bis-phenyl-(1, 1-biphenyl)-4, 4-diamine) 화합물을 400Å의 두께로 열 진공 증착하여 정공 수송층을 형성하였다.N, N-bis- (1-naphthalenyl) -N, N-bis-phenyl- (1,1- biphenyl) -4,4- diamine compound of the following structure was deposited on the hole injection layer to a thickness of 400 Å The hole transport layer was formed by thermal vacuum deposition.
이어서, 상기 정공 수송층 위에 막 두께 300Å으로 위에 제조예 3에서 제조된 화학식 3의 화합물을 Ir(ppy)3 도펀트와 10% 농도로 진공증착 하여 발광층을 형성하였다.Next, on the hole transport layer, a compound of
상기 발광층 위에 아래와 같은 전자 수송 물질을 200Å의 두께로 진공 증착하여 전자 주입 및 수송층을 형성하였다.The following electron transport material was vacuum deposited on the light emitting layer to a thickness of 200 Å to form an electron injection and transport layer.
[전자 수송 물질][Electron transport material]
상기 전자 주입 및 수송층 위에 순차적으로 12Å 두께로 리튬 플루라이드(LiF)와 2,000Å 두께로 알루미늄을 증착하여 음극을 형성하였다.Lithium fluoride (LiF) and aluminum were deposited to a thickness of 12 Å on the electron injection and transport layer sequentially to form a cathode.
상기의 과정에서 유기물의 증착속도는 0.4 ~ 0.7 Å/sec를 유지하였고, 음극의 리튬플루오라이드는 0.3 Å/sec, 알루미늄은 2 Å/sec의 증착 속도를 유지하였으며, 증착시 진공도는 2 × 10-7 ~ 5 × 10-8 torr를 유지하였다.The deposition rate of the organic material was maintained at 0.4 to 0.7 Å / sec, the lithium fluoride at the cathode was maintained at a deposition rate of 0.3 Å / sec, and the deposition rate of aluminum was maintained at 2 Å / sec. -7 to 5 x 10 < -8 > torr.
<< 실험예Experimental Example 2> 2>
상기 실험예 1에서 화학식 3 화합물 대신 화학식 15 화합물을 사용한 것 이외에는 동일하게 실험하였다.In the same manner as in Experimental Example 1, except that the compound of Formula 15 was used instead of the compound of
<< 실험예Experimental Example 3> 3>
상기 실험예 1에서 화학식 3 화합물 대신 화학식 24 화합물을 사용한 것 이외에는 동일하게 실험하였다.In the same manner as in Experimental Example 1, except that the compound of Formula 24 was used instead of the compound of
<< 실험예Experimental Example 4> 4>
상기 실험예 1에서 화학식 3 화합물 대신 화학식 38 화합물을 사용한 것 이외에는 동일하게 실험하였다.In the same manner as in Experimental Example 1, except that the compound of Formula 38 was used instead of the compound of
<< 실험예Experimental Example 5> 5>
상기 실험예 1에서 화학식 3 화합물 대신 화학식 47 화합물을 사용한 것 이외에는 동일하게 실험하였다.In the same manner as in Experimental Example 1, except that the compound of Formula 47 was used instead of the compound of
<< 실험예Experimental Example 6> 6>
상기 실험예 1에서 화학식 3 화합물 대신 화학식 53 화합물을 사용한 것 이외에는 동일하게 실험하였다.In the same manner as in Experimental Example 1, except that the compound of Formula 53 was used instead of the compound of
<< 실험예Experimental Example 7> 7>
상기 실험예 1에서 화학식 3 화합물 대신 화학식 63 화합물을 사용한 것 이외에는 동일하게 실험하였다.In the same manner as in Experimental Example 1, except that the compound of Formula 63 was used instead of the compound of
<< 비교예Comparative Example 1> 1>
상기 실험예 1에서 화학식 3의 화합물 대신 하기의 H1을 사용한 것 이외에는 동일하게 실험하였다.In the same manner as in Experimental Example 1, except that the following H1 was used in place of the compound of Formula 3:
<< 비교예Comparative Example 2> 2>
상기 실험예 1에서 화학식 3의 화합물 대신 하기의 H2를 사용한 것 이외에는 동일하게 실험하였다.In the same manner as in Experimental Example 1, except that the following H2 was used in place of the compound of Formula 3:
상기 실험예 1 ~ 7 및 비교예 1~2 에서 각각의 화합물을 발광층으로 사용하여 제작한 소자결과를 표 8에 나타내었다.Table 8 shows the results of devices manufactured using the compounds of Examples 1 to 7 and Comparative Examples 1 and 2 as the light emitting layer.
(Dopant)Dopant
(Dopant)
(%)Doping concentration
(%)
@5,000 cd/m2 The driving voltage (V)
@ 5,000 cd / m 2
(Cd/A)Luminous efficiency
(Cd / A)
상기 표 1에서 확인할 수 있듯이 실험예 1 내지 7은 본 명세서의 화합물이 녹색 발광층의 호스트로 이용될 수 있고, 비교예 1과 2 보다 향상된 효율을 나타낼 수 있다는 것을 나타내었다.As can be seen from the above Table 1, Examples 1 to 7 show that the compound of the present invention can be used as a host of a green light emitting layer and can exhibit an improved efficiency than Comparative Examples 1 and 2. [
1: 기판
2: 양극
3: 발광층
4: 음극
5: 정공주입층
6: 정공수송층
7: 전자수송층 1: substrate
2: anode
3: light emitting layer
4: cathode
5: Hole injection layer
6: hole transport layer
7: Electron transport layer
Claims (12)
A compound which is any one selected from the following structural formulas:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150161021A KR101991428B1 (en) | 2015-11-17 | 2015-11-17 | Heterocyclic compound and organic electronic device using the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150161021A KR101991428B1 (en) | 2015-11-17 | 2015-11-17 | Heterocyclic compound and organic electronic device using the same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20170057660A KR20170057660A (en) | 2017-05-25 |
KR101991428B1 true KR101991428B1 (en) | 2019-06-20 |
Family
ID=59050780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150161021A KR101991428B1 (en) | 2015-11-17 | 2015-11-17 | Heterocyclic compound and organic electronic device using the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101991428B1 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102626318B1 (en) * | 2016-11-17 | 2024-01-18 | 엘티소재주식회사 | Compound and organic light emitting device using the same |
KR102017790B1 (en) * | 2017-04-13 | 2019-09-03 | 주식회사 엘지화학 | Novel hetero-cyclic compound and organic light emitting device comprising the same |
EP3502108A1 (en) | 2017-12-20 | 2019-06-26 | Samsung Electronics Co., Ltd. | Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the composition |
JP7145608B2 (en) * | 2017-12-20 | 2022-10-03 | 三星電子株式会社 | Compound for organic electroluminescence device, liquid composition, ink composition, thin film, and organic electroluminescence device |
KR102244880B1 (en) * | 2018-01-29 | 2021-04-26 | 주식회사 엘지화학 | Organic light emitting device |
KR102322698B1 (en) | 2018-06-22 | 2021-11-09 | 엘티소재주식회사 | Heterocyclic compound, organic light emitting device comprising the same, composition for organic layer of organic light emitting device and method for manufacturing organic light emitting device |
KR102559589B1 (en) * | 2018-07-06 | 2023-07-25 | 솔루스첨단소재 주식회사 | Organic compound and organic electroluminescent device including the same |
WO2020071863A1 (en) * | 2018-10-04 | 2020-04-09 | 주식회사 엘지화학 | Compound and organic light emitting diode comprising same |
KR102336599B1 (en) | 2018-11-16 | 2021-12-07 | 주식회사 엘지화학 | Novel compound and organic light emitting device comprising the same |
KR102703802B1 (en) * | 2018-12-17 | 2024-09-05 | 솔루스첨단소재 주식회사 | Organic compound and organic electroluminescent device using the same |
KR102312963B1 (en) * | 2018-12-26 | 2021-10-14 | 엘티소재주식회사 | Compound, composition and organic optoelectronic device and display device |
CN113195478B (en) * | 2019-02-01 | 2024-09-03 | 株式会社Lg化学 | Compound and organic light-emitting diode comprising same |
CN113195477B (en) * | 2019-02-01 | 2024-08-20 | 株式会社Lg化学 | Compound and organic light emitting device comprising the same |
KR102353156B1 (en) * | 2019-02-01 | 2022-01-19 | 주식회사 엘지화학 | Compound and organic light emitting device comprising the same |
KR102339005B1 (en) * | 2019-02-01 | 2021-12-14 | 주식회사 엘지화학 | Compound and organic light emitting device comprising the same |
KR102359899B1 (en) * | 2019-02-01 | 2022-02-09 | 주식회사 엘지화학 | Compound and organic light emitting device comprising the same |
CN110305124B (en) * | 2019-05-24 | 2024-07-30 | 浙江华显光电科技有限公司 | Triazine compound and organic light-emitting device containing same |
CN111018847A (en) * | 2019-10-31 | 2020-04-17 | 陕西莱特光电材料股份有限公司 | Nitrogen-containing compound, electronic component, and electronic device |
CN114096535A (en) * | 2019-11-21 | 2022-02-25 | Lt素材株式会社 | Heterocyclic compound, organic light-emitting element comprising same, composition for organic layer of organic light-emitting element, and method for producing organic light-emitting element |
KR20210079553A (en) * | 2019-12-20 | 2021-06-30 | 엘티소재주식회사 | Heterocyclic compound and organic light emitting device comprising same |
CN113024515B (en) * | 2019-12-25 | 2022-05-31 | 南京高光半导体材料有限公司 | Organic electroluminescent compound and organic electroluminescent device |
CN111072637B (en) * | 2019-12-27 | 2023-04-07 | 吉林奥来德光电材料股份有限公司 | Organic light-emitting compound, preparation method thereof and organic light-emitting device |
KR102334762B1 (en) * | 2019-12-27 | 2021-12-06 | 엘티소재주식회사 | Heterocyclic compound, organic light emitting device comprising same and composition for organic layer of organic light emitting device |
CN111269219B (en) * | 2020-03-25 | 2023-05-30 | 烟台显华化工科技有限公司 | Organic luminescent material and organic electroluminescent device |
WO2023033583A1 (en) * | 2021-09-02 | 2023-03-09 | 에스케이머티리얼즈제이엔씨 주식회사 | Compound, organic electroluminescent element, and display device |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013168534A1 (en) * | 2012-05-09 | 2013-11-14 | コニカミノルタ株式会社 | Organic electroluminescence element, production method for organic electroluminescence element, display device, and illumination device |
KR101512059B1 (en) * | 2014-10-06 | 2015-04-14 | 덕산네오룩스 주식회사 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004535099A (en) | 2001-04-20 | 2004-11-18 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Image processing device and method for improving an image, and image display device having the image processing device |
KR20150061174A (en) * | 2013-11-26 | 2015-06-04 | 주식회사 두산 | Organic compounds and organic electro luminescence device comprising the same |
KR102255197B1 (en) * | 2014-05-02 | 2021-05-25 | 삼성디스플레이 주식회사 | Organic light emitting device |
KR102308117B1 (en) * | 2014-10-17 | 2021-10-01 | 삼성전자주식회사 | Carbazole-based compound and organic light emitting device including the same |
JP5831654B1 (en) * | 2015-02-13 | 2015-12-09 | コニカミノルタ株式会社 | Aromatic heterocycle derivative, organic electroluminescence device using the same, illumination device and display device |
WO2017078494A1 (en) * | 2015-11-06 | 2017-05-11 | 희성소재(주) | Heterocyclic compound and organic light emitting device using same |
-
2015
- 2015-11-17 KR KR1020150161021A patent/KR101991428B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013168534A1 (en) * | 2012-05-09 | 2013-11-14 | コニカミノルタ株式会社 | Organic electroluminescence element, production method for organic electroluminescence element, display device, and illumination device |
KR101512059B1 (en) * | 2014-10-06 | 2015-04-14 | 덕산네오룩스 주식회사 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof |
Also Published As
Publication number | Publication date |
---|---|
KR20170057660A (en) | 2017-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101991428B1 (en) | Heterocyclic compound and organic electronic device using the same | |
JP6648882B2 (en) | Organic light emitting device | |
KR102010397B1 (en) | Compound and organic light emitting device using the same | |
JP2019513131A (en) | Novel heterocyclic compound and organic light emitting device using the same | |
KR102222042B1 (en) | Organic light emitting device | |
JP2019515877A (en) | Compound and organic electronic device containing the same | |
KR101626524B1 (en) | An electroluminescent compound and an electroluminescent device comprising the same | |
KR20190103788A (en) | Organic light emitting device | |
US11910711B2 (en) | Cyclic compound and organic light emitting device comprising same | |
KR102342781B1 (en) | Novel compound and organic light emitting device comprising the same | |
KR102120516B1 (en) | Heterocyclic compound and organic light emitting device using the same | |
JP6624284B2 (en) | Amine compound and organic light emitting device containing the same | |
JP6707805B2 (en) | Compound and organic electronic device containing the same | |
KR102126884B1 (en) | Hetero-cyclic compound and organic light emitting device comprising the same | |
KR101891432B1 (en) | Amine based compound and organic electronic device using the same | |
US20220069223A1 (en) | Organic light-emitting device | |
KR102278532B1 (en) | Novel compound and organic light emitting device comprising the same | |
JP6508657B2 (en) | Heterocyclic compound and organic light emitting device containing the same | |
JP2018534238A (en) | Heterocyclic compound and organic light emitting device including the same | |
KR101983340B1 (en) | Heterocyclic compound and organic light emitting device using the same | |
KR101924137B1 (en) | Compound and organic electronic device comprising the same | |
KR101908219B1 (en) | Heterocyclic compound and organic light emitting device comprising the same | |
KR102278531B1 (en) | Novel compound and organic light emitting device comprising the same | |
KR20200086233A (en) | Novel compound and organic light emitting device comprising the same | |
KR101856900B1 (en) | Polycyclic compound and organic light emitting device using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) |